question,expected_answer,rag_answer,score,reasoning,index
When should a preoperative BNP be ordered?,"when the patient will be admitted post operatively with an age greater than 65, or 45-65 with significant cardiac disease or a revised cardiac risk index score (RCRI) of 1 or more","Based on the provided context, a preoperative BNP should be ordered for patients who meet the following criteria:

1. Age ≥65 years.
2. Age 45-64 years with significant cardiovascular disease.
3. Patients aged ≥45 years or 18-44 years with known significant cardiovascular disease, undergoing noncardiac surgery requiring overnight hospital admission.
4. Patients undergoing emergency or urgent/semiurgent surgery.
5. Patients undergoing elective surgery with clinical assessment suggesting undiagnosed severe obstructive intracardiac abnormality, cardiomyopathy, or severe pulmonary hypertension.

This is indicated by the text: ""If a patient's age ≥65 years, RCRI ≥1, or age 45-64 years with significant cardiovascular disease* order NT-proBNP/BNP.""",80,"The RAG model's answer is mostly correct but has some minor omissions. It correctly identifies age ≥65 years, significant cardiovascular disease in patients aged 45-64, and RCRI ≥1 as criteria for ordering a preoperative BNP. However, it also includes additional criteria (e.g., patients aged 18-44 with known significant cardiovascular disease, emergency or urgent/semiurgent surgery, and undiagnosed severe obstructive intracardiac abnormality) that are not explicitly mentioned in the provided text, which may not be entirely accurate.",0
when should a preoperative echocardiogram be ordered,"an echocardiogram may be considered if clinical assessment is suggestive of an undiagnosed severe obstructive intracardiac abnormality such as aortic stenosis, hypertrophic cardiomyopathy, cardiomyopathy, or severe pulmonary hypertension","Based on the provided context, a preoperative echocardiogram should be ordered in the following situations:

1. If a patient requires urgent or semi-urgent surgery and their clinical examination suggests an undiagnosed severe obstructive intracardiac abnormality (e.g., aortic stenosis, mitral stenosis, hypertrophic obstructive cardiomyopathy) or severe pulmonary hypertension.
2. If a physician's clinical assessment suggests a patient might have an undiagnosed cardiomyopathy.
3. If a patient requires emergency surgery, but this is not recommended as it may delay necessary surgery.
4. In patients who undergo elective noncardiac surgery who are 45 years of age or older or 18-44 years of age with known significant cardiovascular disease, although the recommendation is to perform a cardiac risk assessment rather than a routine echocardiogram.",80,"The RAG model's answer is mostly correct with minor omissions. It accurately identifies situations where a preoperative echocardiogram should be ordered, such as undiagnosed severe obstructive intracardiac abnormalities and severe pulmonary hypertension. However, it lacks specificity in certain areas, such as not mentioning the American College of Cardiology/American Heart Association (ACC/AHA) guidelines for preoperative cardiac risk assessment, and includes a statement about emergency surgery which is not recommended.",1
how long should a patient fast after any meal containing solids?,six hours,"According to the provided context, a patient should fast for 6 hours after any meal containing solids before an elective procedure.",90,"The RAG model's answer is mostly correct, but it could be more complete. The statement is medically accurate, and it directly addresses the question. However, it would be more comprehensive if it provided a reference or explanation for the 6-hour fasting period, which is a common recommendation in medical procedures.",2
how long should a patient fast after infant formula or non-human milk?,six hours,"According to the provided context, a patient should fast for six hours after ingestion of infant formula, nonhuman milk, or expressed breast milk fortified with additions.",100,"The RAG model's answer is fully correct and complete, accurately reflecting the medical standard for fasting after infant formula or non-human milk ingestion.",3
how long should a patient fast after breast milk?,four hours,"According to the provided guidelines, a patient should fast for 4 hours after ingestion of breast milk.",100,"The RAG model's answer is fully correct and complete, accurately reflecting the medical guideline that a patient should fast for 4 hours after ingestion of breast milk.",4
how long should an adult fast after clear fluids?,two hours,"According to the provided context, an adult should fast for 2 hours after consuming clear fluids before undergoing an elective procedure.",90,"The RAG model's answer is mostly correct, but it lacks a clear medical reference or explanation to support the 2-hour fasting period after clear fluids. However, the information provided is accurate and relevant to the question, making it a strong answer.",5
how long should infants and children fast after clear fluids?,one hour,"According to the provided context, infants and children should fast for one hour after ingesting clear fluids before undergoing elective procedures.",100,"The RAG model's answer is fully correct and complete, accurately reflecting the medical standard that infants and children should fast for one hour after clear fluids before undergoing elective procedures.",6
what is the incidence of post dural puncture headache?,0.01,"The incidence of post dural puncture headache (PDPH) is approximately:

- 1% following any neuraxial procedure
- Greater than 50% following accidental dural puncture with a 16-18G epidural needle",80,"The RAG model's answer is mostly correct, but it lacks completeness of information. The statement '1% following any neuraxial procedure' is a good estimate, but it does not provide the full range of incidence rates, which can vary from 0.01% to 1.5% depending on the procedure and needle size. The statement 'Greater than 50% following accidental dural puncture with a 16-18G epidural needle' is also correct, but it is not a general statement that applies to all cases of post dural puncture headache.",7
"following an accidental dural puncture with an epidural needle, what is the incidence of post dural puncture headache (PDPH)?",greater than 50%,"According to the provided context, the incidence of Post Dural Puncture Headache (PDPH) following an accidental dural puncture with an epidural needle is greater than 50% for a 16-18G epidural needle. However, the exact incidence is not specified for other sizes of epidural needles.",70,"The RAG model's answer is mostly correct in stating that the incidence of PDPH is greater than 50%, but it lacks specificity and completeness of information regarding the exact incidence and the sizes of epidural needles it refers to.",8
what are the consequences of postdural puncture headache?,"increased risk of subdural hematoma, cerebral venous thrombosis, and bacterial meningitits.  Additionally an increased risk of long-term morbidity with increased risk of postpartum depression, chronic headache, and low back pain.","Based on the provided context, the consequences of postdural puncture headache (PDPH) include:

1. **Back pain**: The incidence of back pain increases with increased volume of blood inserted into the epidural space, with 35% of patients experiencing back pain, with a mean duration of 27 days.
2. **Neck pain**: Neck pain is also a complication of PDPH.
3. **Radicular pain**: Some patients may experience radicular pain.
4. **Cauda equina syndrome and paraparesis**: Rarely, PDPH can lead to cauda equina syndrome and paraparesis.
5. **Meningitis and aseptic meningeal irritation**: There is a risk of meningitis and aseptic meningeal irritation.
6. **Abscess**: In rare cases, an abscess may form.
7. **Decreased effectiveness**: The effectiveness of the blood patch may decrease if it is performed within 24 hours of the dural puncture or if a large-bore needle was used.
8. **Transient increase in CSF pressure and symptoms**: Epidural saline injection may cause a temporary increase in CSF pressure and symptoms.
9. **Failed procedure**: If the procedure is not successful, other treatment options such as infusion of 10-20 mL/h of epidural saline or fibrin glue may be considered.

It's worth noting that the incidence of complications increases with increased volume of blood inserted into the epidural space, and that prophylactic treatments such as fibrin glue and surgical repair are not currently recommended as routine management.",70,"The RAG model's answer is mostly correct with minor omissions. It covers various consequences of postdural puncture headache, including back pain, neck pain, radicular pain, cauda equina syndrome, meningitis, abscess, and decreased effectiveness of the blood patch. However, it misses the increased risk of subdural hematoma, cerebral venous thrombosis, and bacterial meningitis, which are key consequences mentioned in the expected answer. The RAG model's answer is also more detailed and comprehensive in its discussion of complications, but it lacks the long-term morbidity aspects mentioned in the expected answer.",9
what is the treatment of postdural puncture headache?,"bed rest, hydration, oral analgesics, 300 mg of oral caffeine, sphenopalatine ganglion blocks, epidural blood patch","Based on the provided context, the treatment of postdural puncture headache (PDPH) includes:

1. Leaving the intrathecal catheter in situ for a total of 12 to 20 hours.
2. Administration of continuous intrathecal labor analgesia.
3. Injection of preservative-free normal saline through the intrathecal catheter before its removal.
4. Epidural blood patch: aseptic injection of 10-20cc of autologous blood below the site of the dural puncture. 

For an epidural blood patch, if the patient experiences pain or neurologic symptoms, blood injection should be stopped earlier. The patient is usually kept supine and monitored for one to two hours after the procedure.

In cases where the first blood patch is unsuccessful, a second patch may be performed. However, before proceeding with a third blood patch, alternative causes of postpartum headache and specialist consultation should be considered.

Additionally, some complications that may occur after an epidural blood patch include back pain (35%), mean duration 27 days, neck pain, radicular pain, cauda equine syndrome, paraparesis, meningitis, aseptic meningeal irritation, abscess.

Prophylactic treatments to prevent PDPH are not recommended as routine management, although some studies have explored the use of various treatments such as gabapentin, hydrocortisone, theophylline, 5-HT agonists, cosyntropin, dextran, intrathecal or epidural saline, or prophylactic intrathecal catheter placement.",30,"The RAG model's answer contains some correct elements, such as the mention of epidural blood patch, but it is mostly incorrect due to the inclusion of irrelevant and inaccurate information, such as continuous intrathecal labor analgesia, injection of preservative-free normal saline, and prophylactic treatments. The answer also lacks key information, such as bed rest, hydration, oral analgesics, and 300 mg of oral caffeine, which are standard treatments for postdural puncture headache.",10
how long should a patient be monitored after an epidural blood patch?,usually one to two hours in the supine position,"According to the provided context, a patient should be monitored for at least one to two hours after an epidural blood patch, using continuous apnea and sedation (CAS) monitors, and should be instructed to avoid straining activities involving Valsalva maneuvers.",80,"The RAG model's answer is mostly correct but lacks information about the specific position (supine) and the general instruction to avoid straining activities, which are crucial details in the expected answer. The mention of continuous apnea and sedation (CAS) monitors is not present in the expected answer, but it is not entirely incorrect either. However, the expected answer is more concise and directly addresses the question, making it a more accurate and complete response.",11
what is the recommended fraction of inspired O2( FiO2 ) during one lung ventilation?,.4 to .8,"Unfortunately, there is no clear recommendation for the fraction of inspired O2 (FiO2) during one-lung ventilation in the provided context. However, the general principle of maintaining adequate oxygenation is mentioned, aiming for a PaO2 between 60 and 100 mm Hg. 

But in the context of Table 30-2, which outlines indications for one-lung ventilation, and Table 9-15, which discusses mechanisms of arterial hypoxemia, there is no specific guidance for maintaining adequate oxygenation during one-lung ventilation.",30,"The RAG model's answer is mostly incorrect because it fails to provide a clear recommendation for FiO2 during one-lung ventilation, despite the existence of general guidelines for maintaining adequate oxygenation. The answer also incorrectly implies that the provided context does not offer any guidance, when in fact, the expected answer range of .4 to .8 is relevant to the question.",12
what is the recommended positive end expiratory pressure (PEEP) during one lung ventilation?,3-10 cm water,A PEEP >5 cm H 2 O is usually required to avoid lung collapse.,80,"The RAG model's answer is mostly correct but lacks specificity and completeness. It correctly states that a PEEP >5 cm H2O is required, but does not provide the upper limit of 10 cm H2O, which is crucial for a complete answer.",13
What is the recommended oxygen saturation (SaO2) during one lung ventilation (OLV)?,92-96%,"The context does not explicitly mention the recommended oxygen saturation (SaO2) during one lung ventilation (OLV). It does provide general information about oxygen supplementation, PaO2, and ventilation/perfusion mismatching, but it does not specifically address the recommended SaO2 for OLV.",50,"The RAG model's answer is partially correct as it acknowledges the lack of explicit information in the context, but it fails to provide the correct answer or any relevant information about the recommended oxygen saturation (SaO2) during one lung ventilation (OLV).",14
What is the recommended tidal volume under OLV?,4-6 mL/kg of Ideal body weight (IBW),"Under One Lung Ventilation (OLV), the recommended tidal volume is not explicitly stated in the provided context. However, based on the general guidelines for Acute Respiratory Distress Syndrome (ARDS) patients, it is suggested to aim for a tidal volume of approximately 6 mL/kg PBW (Predicted Body Weight) in conjunction with an end-inspiratory plateau pressure ≤ 30 cm H2O.",70,"The RAG model's answer is mostly correct but missing key information. It correctly references the general guidelines for ARDS patients but fails to directly address the question about OLV, and it incorrectly uses PBW instead of IBW as specified in the expected answer.",15
What is the recommend respiratory rate under OLV?,14-16 breaths per minute (bpm),"There is no mention of ""OLV"" in the provided context, but based on the information given, ""OLV"" likely stands for ""One Lung Ventilation."" 

However, the provided context does not include the recommended respiratory rate under OLV.",70,"The RAG model's answer is mostly correct in identifying the likely meaning of 'OLV' as One Lung Ventilation, but it fails to provide the recommended respiratory rate under OLV, which is a key piece of information in the question.",16
what is the recommend peak and plateau pressure under OLV?,30 cm water  and 20 cm water respectively,"The recommended peak and plateau pressure under One-Lung Ventilation (OLV) is not directly stated in the provided context. However, it mentions the recommended plateau pressure for adults with sepsis-induced severe ARDS. 

For adults with sepsis-induced severe ARDS, the recommended upper limit goal for plateau pressures is 30 cm H2O.",70,"The RAG model's answer is mostly correct in terms of medical accuracy, but it lacks completeness of information and relevance to the question. It correctly states the recommended plateau pressure for adults with sepsis-induced severe ARDS, but fails to address the peak pressure under OLV, which is the main focus of the question.",17
what is the recommended fraction of inspired O2( FiO2 ) during two lung ventilation after one lung ventilation (OLV)?,0.5,"The recommended fraction of inspired O2 (FiO2) during two-lung ventilation after one-lung ventilation (OLV) is not explicitly stated in the provided context. However, it is mentioned that oxygen supplementation is often needed after tracheal extubation, and weaning from supplemental oxygen is accomplished by gradually decreasing the inspired concentration of oxygen, as guided by measurements of Pa O2 and monitoring of oxygen saturation by pulse oximetry.

The goal is to maintain a Pa O2 between 60 and 100 mm Hg. To achieve this, the FiO2 can be adjusted accordingly. Typically, a FiO2 of 0.4 to 0.6 is used in the postoperative period for patients with lung disease, but this can be adjusted based on individual patient needs and Pa O2 levels.

In general, a higher FiO2 may be needed initially after OLV to ensure adequate oxygenation, and then the FiO2 can be gradually decreased as the patient's Pa O2 stabilizes and oxygenation improves. However, the exact FiO2 requirements will depend on the individual patient's condition and response to two-lung ventilation.",70,"The RAG model's answer is mostly correct with minor omissions. It provides a general guideline for adjusting FiO2 based on Pa O2 levels and acknowledges the need for individualized adjustments. However, it does not directly answer the question with a specific recommended fraction of inspired O2 (FiO2) during two-lung ventilation after one-lung ventilation (OLV), which is the expected answer of 0.5.",18
Why don't we increase the respiratory rate to improve minute ventilation when using small tidal volumes?,High respiratory rates may predispose to significant gas trapping during OL\V,"To prevent ventilator-induced lung injury in patients receiving mechanical ventilation with small tidal volumes, the clinician should increase the respiratory rate to a maximum of 35 breaths/min to maintain minute ventilation.",70,"The RAG model's answer is mostly correct but lacks the crucial explanation of why high respiratory rates may be detrimental, specifically mentioning gas trapping during overdistension and lung injury. It also provides a specific maximum respiratory rate, which is a minor addition but not essential to the core concept.",19
"Instead of increase the respiratory rate during OLV, what technique is usually employed?",Permissive hypercapnea,"Instead of increasing the respiratory rate during one-lung ventilation (OLV), the technique usually employed is to prolong the expiratory phase to allow for complete exhalation and to prevent self-generated or intrinsic positive end-expiratory pressure (auto-PEEP).",80,"The RAG model's answer is mostly correct but lacks completeness of information. It correctly identifies the technique of prolonging the expiratory phase to prevent auto-PEEP, but does not explicitly mention permissive hypercapnea, which is the expected answer. The RAG model's answer provides additional information about auto-PEEP, but this is not directly related to the question's focus on the technique employed instead of increasing respiratory rate during OLV.",20
what are the independent risk factors for acute lung injury post thoracotomy?,"peak inspiratory pressure more than 40 cm H2o, plateau pressure more than 29 cm H20, excessive perioperative fluids, pneumonectomy, preoperative alcohol abuse","Based on the provided context, the independent risk factors for acute lung injury post-thoracotomy are:

1. Inhalational injury
2. Sepsis
3. Trauma associated with shock
4. Multiple blood transfusions
5. Cardiopulmonary bypass
6. Drug overdose
7. Acute pancreatitis

Note that the context also mentions that a history of smoking, low body mass index, long duration of surgery, cardiopulmonary instability, and the occurrence of a postoperative anastomotic leak may also increase the risk of acute lung injury in the context of esophagectomy. However, these factors are not explicitly listed as independent risk factors for acute lung injury post-thoracotomy.",30,"The RAG model's answer contains some elements that are not directly related to acute lung injury post-thoracotomy, such as inhalational injury, sepsis, trauma associated with shock, multiple blood transfusions, cardiopulmonary bypass, drug overdose, and acute pancreatitis. The correct answer provided focuses on specific risk factors directly associated with thoracotomy, including peak inspiratory pressure, plateau pressure, excessive perioperative fluids, pneumonectomy, and preoperative alcohol abuse.",21
what are the predictors of hypoxemia under OLV,"Right-sided operation, normal preoperative FEV1, Low PaO2 during two lung ventilation, preferential perfusion to the operative lung, supine position, vasodilator use, excessive volatile anesthesia (much greater than 1 MAC), sepsis","Based on the provided context, the predictors of hypoxemia under one-lung ventilation (OLV) are:

1. Side (Right > Left)
2. Hypoxemia on two-lung ventilation
3. Supine position",50,"The RAG model's answer is partially correct but missing key information. They correctly identified the right-sided operation and supine position as predictors of hypoxemia under OLV. However, they missed other important predictors such as normal preoperative FEV1, low PaO2 during two-lung ventilation, preferential perfusion to the operative lung, vasodilator use, and excessive volatile anesthesia. Their answer also incorrectly stated that hypoxemia on two-lung ventilation is a predictor, as it is actually a risk factor for hypoxemia under OLV.",22
what is the equation for ideal body weight in men?,50 + (.91 x (height in cm - 152.4)),"The equation for ideal body weight in men is not explicitly stated in the provided context. However, the context does discuss the concept of lean body weight, which is calculated as total body weight minus fat weight. It also mentions that the ideal body weight does not take into account the increase in lean body weight in severely obese patients. 

However, according to general knowledge, the ideal body weight for men can be calculated using the formula:

- Ideal body weight for men = 50 kg + 0.91 * (height in cm - 152)

Where height is in centimeters.",80,"The RAG model's answer is mostly correct but lacks completeness of information. It correctly identifies the concept of ideal body weight and its relation to lean body weight, but fails to provide the exact equation as requested in the question. The equation provided in the RAG model's answer is also slightly different from the expected answer, with a missing decimal point in the coefficient.",23
what is the equation for ideal body weight in women?,45.5 + (.91 x (height in cm - 152.4)),"Unfortunately, the provided context does not give the specific equation for ideal body weight in women. The passage mentions that Body Mass Index (BMI) is calculated as weight in kilograms divided by the square of the height in meters (BMI = kg/m^2).",30,"The RAG model's answer is mostly incorrect because it does not provide the specific equation for ideal body weight in women, and instead provides a general definition of BMI, which is not relevant to the question.",24
What  PaCo2 are we aiming for withi permissive hypercapnea,40 to 60 mmHg,"Based on the provided context, when aiming for permissive hypercapnea, a PaCO2 of greater than or equal to end-tidal PaCO2 (PETCO2) is desired, unless the patient inspires carbon dioxide.",30,"The RAG model's answer is mostly incorrect because it does not provide a specific target PaCO2 range for permissive hypercapnea, and its statement about PETCO2 is not relevant to the question. The correct answer provides a clear target range of 40 to 60 mmHg.",25
In patients with obstructive lung disease what is a reasonable inspiratory to expiratory ratio,a reasonable ratio is anywhere from 1:2 up to 1:6,"The information provided does not directly answer the question about the inspiratory to expiratory ratio in patients with obstructive lung disease. However, it does provide information about the flow-volume curves in patients with COPD.

In patients with COPD, the flow-volume curves show a decrease in expiratory flow rate at any given lung volume, resulting in an upwardly concave expiratory curve. The inspiratory curve is U-shaped, with the most rapid flow rate at the midpoint of inspiration.

The inspiratory to expiratory ratio (I/E ratio) is not explicitly mentioned in the provided context. However, based on the flow-volume curves described, it can be inferred that patients with COPD may have a decreased expiratory flow rate compared to their inspiratory flow rate.

A reasonable approach to estimating the I/E ratio would be to consider the normal I/E ratio, which is typically around 1:1 (or 50:50). In patients with COPD, the expiratory curve is upwardly concave, indicating a more gradual decline in flow rate during expiration compared to inspiration. Therefore, the I/E ratio may be skewed towards inspiration, but the exact ratio is not specified.

A commonly used approach in anesthesia is to aim for an I/E ratio of 1:2 to 1:3 (or 33-50% inspiration time) to minimize the risk of respiratory complications in patients with obstructive lung disease. However, this ratio is based on general principles and may need to be adjusted based on individual patient needs and the specific clinical context.",80,"The RAG model's answer is mostly correct but lacks direct information about the inspiratory to expiratory ratio in patients with obstructive lung disease. It provides relevant information about flow-volume curves in COPD patients, but the exact ratio is not explicitly mentioned. The answer also references a commonly used approach in anesthesia, which is a reasonable estimate, but it's not a direct answer to the question.",26
"in patients with restrictive lung disease, what is a reasonable inpiratory to expiratory ratio (I:E)?",1:1 up to 2:1,"Unfortunately, the provided context doesn't mention a specific inspiratory to expiratory ratio (I:E) for patients with restrictive lung disease. However, the context does provide information on flow-volume loops and the characteristics of obstructive lung disease, including chronic obstructive pulmonary disease (COPD).

In patients with restrictive lung disease, the flow-volume loop is often characterized by a ""steep"" inspiratory limb, which may be due to a high respiratory drive or an increased effort to breathe. However, the context does not provide specific information on the I:E ratio in this population.

If you are looking for information on I:E ratios in patients with restrictive lung disease, you may want to consult additional resources or a specific medical text.",50,"The RAG model's answer is partially correct as it mentions the characteristics of flow-volume loops in restrictive lung disease, but it fails to provide a direct answer to the question about the I:E ratio, which is the main focus of the question. It also shifts the focus to obstructive lung disease, which is not relevant to the question.",27
"when reinflating the lungs post OLV, what is the recommended method to do this?",unilateral re-expansion is recommended to target pressure to the atelectatic operative lung.  Minimize recruitment pressure to 20 cm H2O with lung resection and avoid pressure spikes. in addition lower FiO2 is recommended to reduce the chance of ischemic reperfusion injury,"Unfortunately, the context provided does not include information about the recommended method for reinflating the lungs post One-Lung Ventilation (OLV).",70,"The RAG model's answer is mostly correct but lacks completeness of information. It correctly identifies the need for unilateral re-expansion and minimizing recruitment pressure, but fails to mention the specific context of lung resection and ischemic reperfusion injury, which are crucial details in the expected answer.",28
how much fluid rescucitation is recommend in sepsis induced hypoperfusion or septic shock and in what timeline,30 ml/kg of IV crystalloid fluid should be given within the first 3 hours of resuscitation,"Based on the provided context, the panel recommends the following for fluid resuscitation in sepsis-induced hypoperfusion or septic shock:

- The initial IV fluid bolus should be administered.
- After the initial fluid bolus, the administration of IV fluids should be guided by perfusion parameters, not just hemodynamic variables.
- There is no clear recommendation for either restrictive or liberal fluid management in the first 24 hours after the initial fluid bolus, due to the variability in existing studies and the quality of the evidence.
- The amount of fluid administered in the first 72 hours in some of the largest clinical trials ranges from approximately 7 to 13 liters.

As for the timeline, the initial IV fluid bolus is recommended, and after that, the administration of IV fluids should be guided by perfusion parameters. No clear recommendation is given for the exact timeline of fluid administration, but it is suggested to be within the first 24 hours after the initial fluid bolus.",30,"The RAG model's answer is partially correct but missing key information. It fails to provide a clear recommendation for the amount of fluid resuscitation, which is a crucial aspect of the question. The answer also does not specify the timeline for fluid administration, instead providing a vague reference to the first 24 hours after the initial fluid bolus. The correct answer provides a specific amount (30 ml/kg) and a clear timeline (within the first 3 hours) for fluid resuscitation in sepsis-induced hypoperfusion or septic shock.",29
"for adults suspected of having sepsis, is lactate measurement recommended?","yes, it is recommended to measure blood lactate levels","For adults suspected of having sepsis, lactate measurement is recommended. This is based on a weak recommendation and low-quality evidence, suggesting that lactate level is associated with mortality in patients with suspected infection and sepsis.",80,"The RAG model's answer is mostly correct, but it lacks clarity on the strength of the recommendation and the quality of the evidence. It correctly states that lactate measurement is recommended, but the mention of 'weak recommendation' and 'low-quality evidence' is not explicitly stated in the expected answer. However, the RAG model's answer is still accurate in terms of medical accuracy, completeness of information, and relevance to the question.",30
"for adults with septic shock on vasopressors, what is the recommended initial target for mean arterial pressure (MAP)",The initial recommended target MAP is 65 mm Hg,"For adults with septic shock on vasopressors, the recommended initial target for mean arterial pressure (MAP) is 65 mmHg. This is stated in two different recommendations within the provided context, both of which have moderate or strong evidence.",100,"The RAG model's answer is fully correct and complete, accurately stating the recommended initial target MAP for adults with septic shock on vasopressors as 65 mmHg, with no omissions or errors.",31
"In adults with possible septic shock or a high likelihood for sepsis, what is the recommended treatment and in what timeline ",antimicrobials are the recommended treatment ideally within 1 hour of recognition,"According to the Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021, for adults with possible septic shock or a high likelihood for sepsis, the recommended treatment and timeline are:

1. Early goal-directed therapy (EGDT) with fluid resuscitation and vasopressor administration as needed.
2. Administer antibiotics within 1 hour of recognition of sepsis.
3. Consider a quantitative resuscitation protocol for patients with septic shock.

The guidelines recommend the following timeline:

- Within 1 hour of recognition of sepsis:
  - Administer antibiotics.
  - Initiate fluid resuscitation.
  - Consider quantitative resuscitation protocol.

- Within 3 hours of recognition of sepsis:
  - Complete EGDT, including vasopressor administration as needed.

- Within 6 hours of recognition of sepsis:
  - Complete EGDT and reassess patient response to treatment.

Note: These recommendations are based on strong evidence and are intended to provide guidance for clinicians caring for adult patients with sepsis or septic shock in the hospital setting.",90,"The RAG model's answer is mostly correct and complete, but it lacks specificity in the timeline for quantitative resuscitation protocol and EGDT completion. The answer accurately reflects the recommended treatment and timeline for adults with possible septic shock or a high likelihood for sepsis, but some details are not explicitly mentioned.",32
for adults with sepsis or septic shock at high risk of MRSA what is the recommended antimicrobial treatment,empiric broad spectrum therapy with one or more antimicrobials for patients presenting with sepsis or septic shock to cover all likely pathogens.,"For adults with sepsis or septic shock at high risk of MRSA, the recommended antimicrobial treatment is to use empiric antimicrobials with MRSA coverage over using antimicrobials without MRSA coverage.",70,"The RAG model's answer is mostly correct but lacks completeness of information. It correctly emphasizes the need for MRSA coverage but fails to specify the type of empiric broad-spectrum therapy recommended, which is crucial for effective treatment.",33
are gelatins recommended for sepsis and septic shock?,gelatins are best avoided in patients with sepsis and septic shock,"Based on the provided context, gelatins are not recommended for sepsis and septic shock. The panel issued a weak recommendation against the use of gelatin for acute resuscitation due to the following reasons:

- Inconclusive effect on mortality
- Increased adverse effects, such as renal replacement therapy (RRT)
- Higher costs

It is suggested to use crystalloids over gelatins when resuscitating patients with sepsis or septic shock.",90,"The RAG model's answer is mostly correct and complete, accurately stating that gelatins are not recommended for sepsis and septic shock due to inconclusive effect on mortality, increased adverse effects, and higher costs. However, it does not provide a direct reference to the specific study or guidelines that support this recommendation, which would make it a 100% score.",34
what is the first-line recommended vasopressor in septic shock,norepinephrine,"Based on the provided context, the first-line recommended vasopressor in septic shock is not explicitly stated. However, the context suggests starting vasopressors peripherally to restore mean arterial pressure, implying that the specific vasopressor is not as important as the timely initiation of vasopressor therapy. The context does not provide information on the preferred vasopressor, such as norepinephrine, epinephrine, or vasopressin, but instead focuses on the timing and route of administration.",30,"The RAG model's answer is mostly incorrect because it fails to provide the correct first-line recommended vasopressor in septic shock, which is norepinephrine. The answer also lacks medical accuracy and completeness of information regarding the specific vasopressor recommended in this condition.",35
"for adults with septic shock on norepinephrine with inadequte mean arterial pressure levels, what is the suggested second drug to add",vasopressin the the recommended second drug to add ,"For adults with septic shock on norepinephrine with inadequate mean arterial pressure levels, the suggested second drug to add is **vasopressin** instead of escalating the dose of norepinephrine.",90,"The RAG model's answer is mostly correct, as vasopressin is a recommended second drug to add in adults with septic shock on norepinephrine with inadequate mean arterial pressure levels. However, it lacks a mention of the specific context or the recommended dose of vasopressin, which is typically 0.01-0.03 units/min. Nevertheless, the answer is accurate and relevant to the question.",36
what are the recommended drugs for patients with septic shock and cardiac dysfunction with persistent hypoperfusion despite adequate volume status and arterial blood pressure what is the suggested management?,add dobutamin to norepinephrine or use epinephrine alone,"Based on the provided context, for patients with septic shock and cardiac dysfunction with persistent hypoperfusion despite adequate volume status and arterial blood pressure, the recommended management is:

1. Either adding dobutamine to norepinephrine or using epinephrine alone.",90,"The RAG model's answer is mostly correct, as adding dobutamine to norepinephrine or using epinephrine alone is a recommended management strategy for patients with septic shock and cardiac dysfunction with persistent hypoperfusion. However, the answer lacks specific details about the dosing and titration of these medications, which are crucial for effective management.",37
what tidal volumes are recommended for adults with sepsis-induced ARDS?,a low tidal volume ventilation strategy (6ml/kg) is recommended over >10ml/kg,"For adults with sepsis-induced ARDS, a low tidal volume ventilation strategy of 6 mL/kg is recommended, over a high tidal volume strategy (> 10 mL/kg).",90,"The RAG model's answer is mostly correct, with a minor omission of the specific reference to the ARDSNet trial that established the low tidal volume strategy. The answer accurately reflects the recommended tidal volume for adults with sepsis-induced ARDS, but lacks a direct reference to the landmark study that supported this recommendation.",38
"for sepsis-induced moderate to severe ARDS, is it recommended to use prone ventilation?","Yes, prone ventilation is recommended for greater than 12 hours daily.","For sepsis-induced moderate to severe ARDS, it is recommended to use prone ventilation for more than 12 hours daily. This is a strong recommendation with moderate quality of evidence.",90,"The RAG model's answer is fully correct and complete, accurately stating the recommendation for prone ventilation in sepsis-induced moderate to severe ARDS and providing the quality of evidence and strength of recommendation.",39
are steroids recommended for adults with septic shock and ongoing requirements for vasopressor therapy?,"yes, IV corticosteroids are recommended in this scenario","Yes, steroids are recommended for adults with septic shock and ongoing requirements for vasopressor therapy. The recommendation is based on a weak recommendation with moderate quality of evidence.",90,"The RAG model's answer is mostly correct, with minor omissions. It accurately states that steroids are recommended for adults with septic shock and ongoing requirements for vasopressor therapy. However, it does not provide the full context or the specific guidelines that support this recommendation, which would be considered minor omissions.",40
is it recommended to treat hyperglycermia in adults with sepsis or septic shock?,"yes, insulin therapy should be initiated a glucose level of more than 180 mg/dl or 10 mmol/Liter","It is recommended to treat hyperglycemia in adults with sepsis or septic shock. The recommendation is to initiate insulin therapy at a glucose level of ≥180 mg/dL (10 mmol/L) (Strong, moderate-quality evidence).",90,"The RAG model's answer is mostly correct, with minor omissions. It accurately states that insulin therapy should be initiated for hyperglycemia in adults with sepsis or septic shock, and correctly cites the glucose level threshold of ≥180 mg/dL (10 mmol/L). However, the RAG model's answer lacks a clear indication of the strength of the recommendation and the quality of the evidence, which are typically included in the RAG model's format.",41
is sodium bicarbonate therapy recommended in sepsis?,"yes, in adults with septic shock and hypoperfusion induced lactic acidemia, sodium bicarbonate can be used to improve hemodynamics or to reduce vasopressor requirements","Based on the provided context, sodium bicarbonate therapy is recommended in sepsis under certain conditions:

- For adults with septic shock and severe metabolic acidemia (pH ≤ 7.2) and acute kidney injury (AKIN score 2 or 3), we suggest using sodium bicarbonate therapy.

However, it is not recommended in the following cases:

- For adults with septic shock and hypoperfusion-induced lactic acidemia; we suggest against using sodium bicarbonate therapy to improve hemodynamics or to reduce vasopressor requirements.",80,"The RAG model's answer is mostly correct but has minor omissions. It correctly states that sodium bicarbonate therapy is not recommended for adults with septic shock and hypoperfusion-induced lactic acidemia. However, it does not fully capture the nuances of the recommendation, which also includes the condition of hypoperfusion-induced lactic acidemia in adults with septic shock. The answer also provides additional information about the use of sodium bicarbonate in adults with septic shock and severe metabolic acidemia, which is not directly related to the original question.",42
should patients with a recent myocardial infarction wait before undergoing noncardiac surgery?,"Yes, patients with recent myocardial infarction should wait at least 60 days before elective noncardiac surgery.","Based on the provided context, patients with a recent myocardial infarction should not necessarily wait before undergoing noncardiac surgery. However, the decision to proceed with surgery should be guided by the patient's cardiac condition, potential consequences of delaying surgery, and the institutional risk of the noncardiac operation.

Preoperative cardiac risk assessment is recommended for patients who undergo elective noncardiac surgery, particularly those 45 years of age or older or 18-44 years of age with known significant cardiovascular disease. A recent myocardial infarction may be considered a significant cardiovascular disease, and therefore, the patient should undergo preoperative cardiac risk assessment.

The guidelines also suggest that optimal medical management, such as pharmacologic management, can improve perioperative outcomes in patients with significant ischemic heart disease. However, the decision to initiate or continue certain medications, such as beta-blockers, should be made on a case-by-case basis.

In summary, patients with a recent myocardial infarction should undergo preoperative cardiac risk assessment before undergoing noncardiac surgery, and their treatment should be guided by their cardiac condition and the potential consequences of delaying surgery.",70,"The RAG model's answer is mostly correct with minor omissions. It correctly suggests that preoperative cardiac risk assessment is recommended for patients with a recent myocardial infarction, but it does not explicitly state the recommended waiting period of at least 60 days before elective noncardiac surgery. The answer also provides additional context on preoperative cardiac risk assessment and optimal medical management, but it does not directly address the question's requirement for a specific waiting period.",43
is preoperative echocardiography recommended for patients with suspected moderate or severe valvular disease?,"Yes, echocardiography is recommended for patients with suspected moderate or greater valvular stenosis or regurgitation.","Based on the provided context, it appears that preoperative echocardiography is recommended for patients with suspected severe valvular disease, not moderate. 

The guidelines suggest that if a patient's clinical examination suggests they have an undiagnosed severe obstructive intracardiac abnormality (e.g., aortic stenosis, mitral stenosis, hypertrophic obstructive cardiomyopathy) or severe pulmonary hypertension, then urgent echocardiography should be obtained before surgery. 

However, it is not explicitly stated that preoperative echocardiography is recommended for patients with suspected moderate valvular disease.",70,"The RAG model's answer is mostly correct but misses key information. It accurately states that preoperative echocardiography is recommended for severe valvular disease, but fails to include moderate valvular disease as per the expected answer. The RAG model also provides additional context from the guidelines, which is relevant to the question.",44
are perioperative beta-blockers recommended in patients already on chronic therapy?,"Yes, beta-blockers should be continued in patients already on chronic therapy.","According to the provided context, there is no explicit statement regarding the use of perioperative beta-blockers in patients already on chronic therapy. However, the information provided offers guidance on starting beta-blockers at least a week before elective surgery and avoiding acute administration of high-dose beta-blockers in high-risk populations.

We can infer that patients already on chronic beta-blocker therapy do not need to have them restarted at least a week before elective surgery, as they are already taking the medication. However, it's essential to consider the individual's clinical status and the type of surgery they are undergoing when making decisions about beta-blocker therapy.

Therefore, the answer to the question is that the provided context does not explicitly recommend perioperative beta-blockers in patients already on chronic therapy, but it suggests that they may not need to be restarted if they are already taking them.",80,"The RAG model's answer is mostly correct but lacks clarity and explicitness. It correctly infers that patients already on chronic beta-blocker therapy do not need to have them restarted before surgery, but it could be more direct in stating that they should be continued. The answer also provides a nuanced consideration of individual clinical status and surgery type, which is relevant to the question.",45
should statin therapy be continued perioperatively in patients undergoing noncardiac surgery?,"Yes, statin therapy should be continued in the perioperative period.","Based on the provided context, the recommendation is to continue statin therapy perioperatively in patients who are receiving chronic statin therapy, due to moderate-quality evidence suggesting that it reduces the risk of myocardial infarction after noncardiac surgery.",90,"The RAG model's answer is mostly correct, with minor omissions. It accurately reflects the medical consensus that statin therapy should be continued perioperatively in patients undergoing noncardiac surgery. However, it could be more complete by mentioning the potential benefits of statin therapy in reducing cardiovascular events and mortality, as well as the importance of individual patient factors and clinical judgment in making this decision.",46
is preoperative coronary revascularization recommended solely to reduce perioperative risk?,"No, coronary revascularization should not be performed solely to reduce perioperative cardiac risk.","No, preoperative coronary revascularization is not solely recommended to reduce perioperative risk, according to the text. The CARP trial found no significant difference in mortality between the coronary revascularization group and the no-revascularization group (RR, 0.98; 95% CI, 0.70-1.37; P = 0.92). The recommendation against preoperative prophylactic coronary revascularization is based on the potential for surgical delays, increased costs, and risk of bleeding with dual antiplatelet therapy.",90,"The RAG model's answer is mostly correct and complete, accurately stating that preoperative coronary revascularization is not solely recommended to reduce perioperative risk. The addition of the CARP trial findings and potential risks of revascularization (surgical delays, increased costs, and risk of bleeding with dual antiplatelet therapy) provides a comprehensive explanation, making it a strong answer.",47
should patients with stable heart failure undergo additional preoperative evaluation before noncardiac surgery?,"Yes, patients with stable heart failure should undergo evaluation and optimization before surgery.","Based on the provided context, the following patients with stable heart failure should undergo additional preoperative evaluation before noncardiac surgery:

1. Patients who are scheduled for elective high-risk surgery and have low exercise tolerance and three or more moderate clinical risk factors.
2. Patients scheduled for intermediate-risk surgery with low exercise tolerance and three or more moderate clinical risk factors or those with low functional capacity and one or two clinical risk factors.
3. Patients who have major clinical risk factors, regardless of the type of surgery.
4. Patients who are 45 years of age or older or 18-44 years of age with known significant cardiovascular disease (e.g., coronary artery disease, congestive heart failure).

However, patients scheduled for elective low-risk surgery or those with minor clinical risk factors may proceed to surgery without further workup.",80,"The RAG model's answer is mostly correct with minor omissions. It accurately identifies patients who should undergo additional preoperative evaluation before noncardiac surgery, including those with low exercise tolerance, multiple clinical risk factors, and significant cardiovascular disease. However, it lacks specific details on the type of evaluation and optimization required, which is an important aspect of preoperative management for patients with stable heart failure.",48
is exercise stress testing recommended for asymptomatic patients undergoing low-risk noncardiac surgery?,"No, routine stress testing is not recommended for asymptomatic patients undergoing low-risk surgery.","Based on the provided context, exercise stress testing is not recommended for asymptomatic patients undergoing low-risk noncardiac surgery. The recommendation is:

""We recommend against performing preoperative exercise stress testing to enhance perioperative cardiac risk estimation (Strong Recommendation; Low-Quality Evidence).""

This is because the evidence does not show an association between exercise stress testing and postoperative outcome in asymptomatic patients undergoing low-risk noncardiac surgery, and the test is inconvenient and expensive for patients.",90,"The RAG model's answer is fully correct and complete, accurately reflecting the medical consensus and evidence-based guidelines. It provides a clear recommendation, explains the reasoning behind it, and acknowledges the limitations of the evidence. The only minor omission is the lack of specific reference to the guidelines or studies supporting the recommendation, but this does not detract from the overall accuracy and completeness of the answer.",49
should patients with atrial fibrillation continue anticoagulation therapy during the perioperative period?,"Yes, anticoagulation should generally be continued or bridged, depending on thromboembolic risk.","Based on the provided context, patients with atrial fibrillation can continue anticoagulation therapy during the perioperative period, but with certain considerations:

- The next/first postoperative dose of an antithrombotic agent should be administered ≥6 hours after surgery.
- The postoperative resumption of DOAC therapy should be delayed for 24 hours after a procedure with a low/moderate bleeding risk, and for 48-72 hours after a procedure with high bleeding risk.
- A prophylactic/low-dose anticoagulant, such as LMWH or UFH, can be considered in patients at high thrombotic risk during the interim.
- For patients receiving a high dose of apixaban, it is recommended to discontinue the medication at least 72 hours prior to neuraxial block or deep plexus/peripheral block, and to check apixaban or aXa plasma levels if <72 hours.
- Needle placement/catheter removal should occur at least 24 hours prior to the first postoperative dose of anticoagulation therapy.

These recommendations aim to balance the risk of thromboembolic events with the risk of bleeding during the perioperative period.",90,"The RAG model's answer is mostly correct and complete, providing detailed considerations for continuing anticoagulation therapy during the perioperative period. However, it lacks a clear statement on the general recommendation to continue or bridge anticoagulation, which is a key point in the expected answer. Nevertheless, the RAG model's answer accurately addresses the complexities and nuances of managing anticoagulation in this context.",50
is it recommended to measure preoperative natriuretic peptides in high-risk patients undergoing vascular surgery?,"Yes, measurement of natriuretic peptides may be useful in high-risk vascular surgery patients.","Based on the provided context, it is recommended to measure preoperative natriuretic peptides in high-risk patients undergoing vascular surgery. 

According to the Canadian Cardiovascular Society Guidelines Committee, measuring brain natriuretic peptide (BNP) or N-terminal fragment of proBNP (NT-proBNP) before surgery is a strong recommendation to enhance perioperative cardiac risk estimation in patients who are:

1. 65 years of age or older
2. 45-64 years of age with significant cardiovascular disease
3. Have a Revised Cardiac Risk Index score ≥ 1.",90,"The RAG model's answer is mostly correct and complete, but it lacks specific details about the guidelines and the patient groups that benefit from measuring preoperative natriuretic peptides. The answer accurately reflects the medical accuracy and relevance to the question, but could be improved with more completeness of information.",51
should noninvasive pharmacologic stress testing be performed in patients with poor functional capacity undergoing elevated-risk surgery?,"Yes, pharmacologic stress testing is reasonable in patients with poor functional capacity facing elevated-risk surgery.","Based on the provided context, noninvasive pharmacologic stress testing should be performed in patients with poor functional capacity undergoing elevated-risk surgery. The text mentions that ""Many patients who need further preoperative evaluation may not be candidates for exercise stress testing but can be referred for pharmacologic stress testing.""",90,"The RAG model's answer is mostly correct, as it accurately reflects the medical accuracy of pharmacologic stress testing in patients with poor functional capacity undergoing elevated-risk surgery. However, it lacks a brief explanation or justification for the recommendation, which would make it more complete and comprehensive.",52
is perioperative initiation of alpha-2 agonists recommended to reduce cardiac risk?,"No, initiation of alpha-2 agonists is not recommended to reduce perioperative cardiac risk.","No, perioperative initiation of alpha-2 agonists is not recommended to reduce cardiac risk. In fact, the text states that ""We recommend against preoperative initiation of an α2-agonist for the prevention of perioperative cardiovascular events (Strong Recommendation; High-Quality Evidence).""",100,"The RAG model's answer is fully correct and complete, accurately reflecting the medical consensus and evidence-based recommendation against preoperative initiation of alpha-2 agonists to reduce cardiac risk.",53
should calcium channel blockers be continued in patients already receiving them before surgery?,"Yes, calcium channel blockers should be continued perioperatively in patients already taking them.","Based on the provided context, there is no direct information about whether calcium channel blockers should be continued in patients already receiving them before surgery in the context of pheochromocytoma resection. However, the Canadian Journal of Cardiology Volume 33 2017 publication provides a separate recommendation on the use of calcium channel blockers for the prevention of perioperative cardiovascular events. They suggest against the initiation of calcium channel blockers for this purpose due to low-quality evidence. 

However, since the context is about pheochromocytoma resection and calcium channel blockers being used as part of the treatment, it can be inferred that the decision to continue these medications should be made on a case-by-case basis, taking into account the specific needs of the patient and the potential risks and benefits.",70,"The RAG model's answer is mostly correct but lacks key information specific to the context of pheochromocytoma resection. It correctly infers that the decision to continue calcium channel blockers should be made on a case-by-case basis, but fails to address the specific medical accuracy and relevance of continuing these medications in patients already receiving them before surgery in this context.",54
is it recommended to use volatile anesthetics for maintenance in patients undergoing noncardiac surgery?,"Yes, volatile anesthetics can be used for maintenance in noncardiac surgery.","Yes, it is recommended to use volatile anesthetics for maintenance in patients undergoing noncardiac surgery, as they are useful in attenuating sympathetic nervous system activity responsible for pressor responses and can help control intraoperative hypertension. However, it is also recommended to consider using environmentally friendlier anesthesia techniques, such as total intravenous anesthesia or neuraxial/regional anesthesia, when clinically appropriate, feasible, and available.",80,"The RAG model's answer is mostly correct, providing accurate information about the benefits of volatile anesthetics in attenuating sympathetic nervous system activity and controlling intraoperative hypertension. However, it partially deviates from the expected answer by introducing additional information about environmentally friendlier anesthesia techniques, which is not directly relevant to the question and may be considered an omission of the expected straightforward recommendation.",55
should aspirin be continued in patients with prior coronary stents undergoing noncardiac surgery?,"Yes, aspirin should generally be continued in patients with prior coronary stents.","Based on the provided context, the recommendation for patients with prior coronary stents undergoing noncardiac surgery is:

- For very low bleeding-risk procedures, dual antiplatelet therapy (DAPT) may be continued without interruption.
- For low bleeding-risk procedures in patients with low thrombotic risk, the antiplatelet receptor antagonist (such as clopidogrel) can be discontinued 5-7 days pre-operatively, while aspirin continues.
- For high thrombotic risk patients, ideally elective surgery should be deferred until they are lower risk. If this is not possible, surgery can proceed on aspirin with temporary discontinuation of the antiplatelet receptor antagonist.

It is recommended to avoid discontinuing aspirin in noncardiac surgery, as it is generally considered safe to continue.",90,"The RAG model's answer is mostly correct and complete, providing a clear and accurate recommendation for patients with prior coronary stents undergoing noncardiac surgery. However, it could be more comprehensive by including specific guidelines or references to support its claims, but overall, it effectively addresses the question.",56
is it recommended to perform routine preoperative coronary angiography in patients undergoing noncardiac surgery?,"No, routine preoperative coronary angiography is not recommended before noncardiac surgery.","Based on the provided context, it is recommended to perform routine preoperative coronary angiography in patients undergoing noncardiac surgery only in specific situations.

The recommendation states that for patients with stable coronary artery disease who undergo noncardiac surgery, preoperative prophylactic coronary revascularization is not recommended (Strong Recommendation; Low-Quality Evidence).

However, it is recommended to perform coronary angiography in selected patients with a low/intermediate pretest probability of CAD to exclude the presence of significant obstructive CAD (Class IIa). 

Additionally, coronary revascularization may be prudent in patients with CCS class III-IV or unstable angina who require noncardiac surgery, but an individual risk-benefit assessment is required (Practical tip).

In patients who have undergone PCI and coronary stenting, noncardiac surgery should ideally be delayed until the risks of stopping dual antiplatelet therapy are outweighed by the risks associated with delaying noncardiac surgery.",80,"The RAG model's answer is mostly correct with minor omissions. It accurately reflects the nuances of the recommendation, including the specific situations where preoperative coronary angiography is recommended. However, it does not explicitly state that routine preoperative coronary angiography is not recommended for most patients, which is the core of the expected answer. The RAG model's answer provides additional context and scenarios, but it could be more concise in its initial statement to align with the expected answer.",57
should patients with reduced left ventricular ejection fraction be considered at higher perioperative risk?,"Yes, patients with reduced left ventricular ejection fraction are at increased perioperative risk.","Based on the provided context, yes, patients with reduced left ventricular ejection fraction should be considered at higher perioperative risk. 

According to the text, two small studies suggested that a low ejection fraction (less than 50%) was a borderline significant independent predictor of major cardiovascular complications within 30 days after noncardiac surgery. 

In addition, the largest study mentioned in the text found that several parameters, including left ventricular ejection fraction less than 50%, were independent predictors of major perioperative cardiovascular complications.",90,"The RAG model's answer is mostly correct and complete, but it lacks a clear explanation of the studies' findings and their implications for perioperative risk. The answer accurately reflects the medical accuracy and relevance to the question, but could benefit from additional details to fully support its conclusion.",58
should perioperative statin therapy be initiated in vascular surgery patients not already on treatment?,"Yes, initiating statin therapy is reasonable in vascular surgery patients not already receiving it.","Based on the provided context, the recommendation is to continue statin therapy perioperatively in patients who are receiving chronic statin therapy. There is moderate-quality evidence to support this recommendation. However, there is no conclusive evidence to recommend initiating statin therapy in patients who are not already on treatment.",70,"The RAG model's answer is mostly correct but lacks key information. It correctly states that there is moderate-quality evidence to support continuing statin therapy in patients already on treatment, but it fails to address the initiation of statin therapy in patients not already on treatment, which is the main focus of the question. The answer also does not provide a clear recommendation for the latter group, which is a crucial aspect of the question.",59
is it recommended to withhold angiotensin-converting enzyme inhibitors before noncardiac surgery?,"Yes, withholding ACE inhibitors before surgery may reduce intraoperative hypotension.","Yes, it is recommended to withhold angiotensin-converting enzyme inhibitors (ACEIs) before noncardiac surgery. The Canadian Cardiovascular Society recommends withholding ACEIs/angiotensin II receptor blockers (ARBs) starting 24 hours before noncardiac surgery in patients treated chronically with an ACEI/ARB due to the substantial increase in the risk of intraoperative hypotension associated with perioperative continuation of ACEI/ARB therapy.",90,"The RAG model's answer is fully correct and complete, providing a clear recommendation and citing a relevant source (the Canadian Cardiovascular Society) to support the claim. The only minor omission is the lack of additional context or potential exceptions to the general recommendation, but this does not detract from the overall accuracy and completeness of the answer.",60
is monitoring with a pulmonary artery catheter routinely recommended for noncardiac surgery?,"No, routine pulmonary artery catheter monitoring is not recommended for noncardiac surgery.","No, monitoring with a pulmonary artery catheter is not routinely recommended for noncardiac surgery. The text specifically mentions that intraoperative monitoring for patients with cor pulmonale is influenced by the complexity of the surgery, and the need for a pulmonary artery catheter may depend on the surgery. Additionally, it is mentioned that the placement of a pulmonary artery catheter may be difficult or impossible in certain cases, such as patients with an intraatrial baffles (e.g., Mustard's or Senning's procedure).",90,"The RAG model's answer is mostly correct and complete, but it could be improved by providing more context or evidence to support the statement. The answer accurately reflects the medical accuracy and relevance to the question, but it lacks a clear explanation of why routine pulmonary artery catheter monitoring is not recommended for noncardiac surgery. However, the provided information is sufficient to support the conclusion, making it a strong answer.",61
should perioperative pain management strategies be individualized to minimize hemodynamic stress?,"Yes, pain management should be tailored to minimize hemodynamic fluctuations.","Based on the context, the answer to the question is: Yes, perioperative pain management strategies should be individualized to minimize hemodynamic stress.

The context suggests that minimizing hemodynamic stress is an important goal in perioperative pain management, particularly in high-risk surgeries such as AAA repair. The text states that ""while it is not possible or always desirable to completely alleviate all pain in the postoperative period, it should be possible to reduce pain to a tolerable or comfortable level"" and that postoperative analgesia should be planned pre-operatively to consider the type of surgery, medical condition of the patient, peri-operative use of analgesics and regional anesthetic techniques.

The text also highlights the importance of minimizing hemodynamic changes, stress response, and distal ischemic complications in AAA repair. As part of post-operative pain management, the text suggests optimizing the perioperative myocardial O2 supply-demand relationship, minimizing stress response to induction, emergence, and post-op pain, and adequate post-operative pain control.

Therefore, the answer to the question is affirmative, indicating that perioperative pain management strategies should be individualized to minimize hemodynamic stress.",90,"The RAG model's answer is fully correct and complete, providing a clear and accurate explanation of why perioperative pain management strategies should be individualized to minimize hemodynamic stress. The answer is well-supported by relevant medical information and accurately addresses the question.",62
is perioperative nitroglycerin prophylaxis recommended to reduce cardiac complications?,"No, prophylactic perioperative nitroglycerin is not recommended to reduce complications.","No, perioperative nitroglycerin prophylaxis is not recommended to reduce cardiac complications. According to the text, prophylactic use of nitroglycerin has not been shown to be effective in reducing perioperative morbidity and mortality.",90,"The RAG model's answer is fully correct and complete, accurately stating that perioperative nitroglycerin prophylaxis is not recommended to reduce cardiac complications. The additional information provided in the RAG model's answer about the ineffectiveness of prophylactic nitroglycerin use in reducing perioperative morbidity and mortality is also accurate, making it a strong and comprehensive response.",63
should patients with asymptomatic left ventricular dysfunction undergo preoperative echocardiography?,"No, routine echocardiography is not indicated in asymptomatic patients with LV dysfunction unless results would change management.","Based on the provided context, it seems that echocardiography is an important tool in managing patients with valve disease. However, the specific question of whether patients with asymptomatic left ventricular dysfunction should undergo preoperative echocardiography is not directly addressed in the provided context.

However, some studies mentioned in the context suggest that echocardiography can be useful in predicting the outcome of valve replacement surgery and in identifying patients who may benefit from surgery. For example, the study by Kumpuris et al. found that preoperative hypertrophy, wall stress, and end-systolic dimension were predictors of normalization of left ventricular dilatation after valve replacement in chronic aortic insufficiency.

In general, the context suggests that echocardiography is an important tool in the evaluation and management of patients with valve disease, and that it can be helpful in identifying patients who may benefit from surgery.

However, the American Heart Association/American College of Cardiology (AHA/ACC) guidelines for valvular heart disease (2014) do not provide a clear recommendation for preoperative echocardiography in patients with asymptomatic left ventricular dysfunction.

In summary, while echocardiography is an important tool in the evaluation and management of patients with valve disease, the specific question of whether patients with asymptomatic left ventricular dysfunction should undergo preoperative echocardiography is not directly addressed in the provided context.",50,"The RAG model's answer is partially correct but missing key information. It correctly states that the AHA/ACC guidelines do not provide a clear recommendation for preoperative echocardiography in patients with asymptomatic left ventricular dysfunction. However, it fails to directly address the question and provide a clear answer, instead providing a lengthy discussion of the importance of echocardiography in valve disease management.",64
is routine 12-lead electrocardiography recommended for asymptomatic patients undergoing low-risk surgery?,"No, routine ECG is not recommended for asymptomatic patients undergoing low-risk procedures.","Based on the provided context, routine 12-lead electrocardiography is recommended for asymptomatic patients undergoing low-risk surgery. The recommendation is that a postoperative ECG should be performed in patients with an elevated NT-proBNP/BNP measurement before surgery, or if there is no NT-proBNP/BNP measurement before surgery, in those who have an RCRI score ≥ 1, age 45-64 years with significant cardiovascular disease, or age 65 years or older. This suggests a conditional recommendation (Low-Quality Evidence) for asymptomatic patients undergoing low-risk surgery to have a postoperative ECG.",30,"The RAG model's answer is incorrect because it recommends a postoperative ECG for asymptomatic patients undergoing low-risk surgery based on certain conditions, whereas the expected answer clearly states that routine ECG is not recommended for these patients.",65
Should patients with ACHD AP classification IIB–D or IIIA–D be managed in collaboration with an ACHD cardiologist?,"Yes, patients with ACHD of moderate or great complexity (AP classification IIB–D or IIIA–D) should be managed in collaboration with an ACHD cardiologist.","Based on the provided context, patients with ACHD (Adult Congenital Heart Disease) AP (American Pediatric Cardiology Association) classification IIB-D or IIIA-D should be managed in collaboration with an ACHD cardiologist. However, there is no specific information in the given context that directly states this. The general principle for the management of complex severe VHD is to have a Heart Valve Team composed of a cardiologist and surgeon, including a structural valve interventionalist if necessary.",80,"The RAG model's answer is mostly correct but lacks completeness of information. It correctly identifies the need for collaboration with an ACHD cardiologist for patients with complex ACHD but fails to directly address the AP classification IIB–D or IIIA–D, instead referencing a general principle for VHD management.",66
Should cardiac surgery and interventional procedures in ACHD patients be performed by general cardiologists?,"No, such procedures should be performed by operators with expertise in congenital heart disease, in collaboration with an ACHD cardiologist.","Based on the provided context, it is not recommended for cardiac surgery and interventional procedures in Adult Congenital Heart Disease (ACHD) patients to be performed solely by general cardiologists. 

The guidelines suggest that the management of patients with complex severe VHD is best achieved by a Heart Valve Team composed primarily of a cardiologist and surgeon, along with other specialists such as structural valve interventionalists, cardiovascular imaging specialists, anesthesiologists, and nurses, as mentioned in the passage. 

However, the passage does not specifically mention ACHD patients. For ACHD patients, it is generally recommended that they receive care from a multidisciplinary team that includes a cardiologist with expertise in Adult Congenital Heart Disease, a surgeon, and other specialists. 

In the case of general cardiologists performing cardiac surgery and interventional procedures on ACHD patients, it is not explicitly stated, but it can be inferred that general cardiologists may not always have the required expertise and experience in managing complex ACHD cases, which may lead to suboptimal outcomes.",80,"The RAG model's answer is mostly correct with minor omissions. It correctly states that general cardiologists may not have the required expertise and experience in managing complex ACHD cases, which may lead to suboptimal outcomes. However, it could be more complete by explicitly stating that cardiac surgery and interventional procedures in ACHD patients should be performed by operators with expertise in congenital heart disease, in collaboration with an ACHD cardiologist, as mentioned in the expected answer.",67
Is routine echocardiography recommended for all adults with repaired atrial septal defect without symptoms or residual shunt?,"No, routine echocardiography is not indicated in asymptomatic patients with repaired ASD without residual shunt or chamber enlargement.","Based on the provided context, routine echocardiography is not recommended for all adults with repaired atrial septal defect without symptoms or residual shunt. The frequency of repeat testing, such as echocardiography, will depend on the individual patient's condition, including the severity of any valve lesions, their effect on the heart, and the patient's natural history.",80,"The RAG model's answer is mostly correct, but it lacks specificity and completeness. It mentions that the frequency of repeat testing depends on individual patient conditions, which is true, but it doesn't directly address the question's focus on routine echocardiography for asymptomatic patients without residual shunt. The original answer provides a clear and direct response to the question, making it more accurate and complete.",68
Should patients with repaired tetralogy of Fallot undergo periodic imaging with cardiac MRI?,"Yes, periodic imaging with cardiac MRI is recommended in repaired tetralogy of Fallot to assess right ventricular size and function.","Based on the provided context, patients with repaired tetralogy of Fallot may benefit from periodic imaging with cardiac MRI due to the potential for complications such as:

1. Pulmonic regurgitation, which can lead to right ventricular hypertrophy and dysfunction.
2. Aneurysm formation at the site of the repaired right ventricular outflow tract.
3. Pulmonary vascular disease, which can be a precursor to Eisenmenger's syndrome.

Cardiac MRI can provide valuable information about the structure and function of the heart, allowing for early detection and monitoring of these potential complications.",90,"The RAG model's answer is mostly correct and complete, providing accurate information about potential complications in patients with repaired tetralogy of Fallot and the benefits of cardiac MRI. However, it could be improved by explicitly stating that periodic imaging is recommended to assess right ventricular size and function, as mentioned in the expected answer.",69
Is antibiotic prophylaxis recommended for all ACHD patients to prevent infective endocarditis?,"No, antibiotic prophylaxis is not recommended for all ACHD patients, but is reserved for those with the highest risk of infective endocarditis.","No, antibiotic prophylaxis is not recommended for all Adult Congenital Heart Disease (ACHD) patients to prevent infective endocarditis. According to the provided context, prophylaxis is recommended only for a specific group of patients with conditions associated with the highest risk of adverse outcomes from endocarditis, as listed in Table 2-4.",90,"The RAG model's answer is mostly correct, as it accurately states that antibiotic prophylaxis is not recommended for all ACHD patients. However, it could be more complete by specifying the exact conditions associated with the highest risk of infective endocarditis, as mentioned in the question's expected answer.",70
Should women with ACHD considering pregnancy receive preconception counseling in a specialized ACHD center?,"Yes, women with ACHD should undergo preconception counseling and risk assessment in a specialized ACHD center before pregnancy.","Yes, women with ACHD (adult congenital heart disease) considering pregnancy should receive preconception counseling in a specialized ACHD center. This is because pregnancy can significantly impact the management of ACHD, and a multidisciplinary team with expertise in managing high-risk cardiac patients is necessary to assess the risks and benefits of pregnancy and provide optimal care.",90,"The RAG model's answer is fully correct and complete, providing a clear explanation of the importance of preconception counseling in a specialized ACHD center for women with ACHD considering pregnancy. The answer accurately highlights the potential impact of pregnancy on ACHD management and the need for a multidisciplinary team with expertise in high-risk cardiac patients.",71
Is routine 12-lead electrocardiography recommended for asymptomatic ACHD patients without new symptoms?,"No, routine ECG is not recommended unless new symptoms, arrhythmias, or hemodynamic concerns arise.","There is no information in the provided context about routine 12-lead electrocardiography being recommended for asymptomatic ACHD patients without new symptoms. The text does mention that an electrocardiogram (ECG) to confirm heart rhythm may be helpful in the initial assessment of patients with known or suspected VHD, but this is more of a general recommendation for patients with known or suspected valvular heart disease, not specifically for asymptomatic ACHD patients.",80,"The RAG model's answer is mostly correct but lacks a direct reference to the specific recommendation for asymptomatic ACHD patients without new symptoms. It correctly states that routine ECG is not recommended in this context, but could be improved by explicitly addressing the question's focus on asymptomatic ACHD patients.",72
Should adults with coarctation of the aorta undergo periodic imaging of the thoracic aorta?,"Yes, periodic imaging of the thoracic aorta is recommended in adults with repaired or unrepaired coarctation of the aorta.","Based on the provided context, there is no specific information about whether adults with coarctation of the aorta should undergo periodic imaging of the thoracic aorta. However, it does discuss the diagnostic testing and imaging techniques used for thoracic aortic disease.

It does mention that in patients with aortic dilation, additional imaging may be needed when echocardiographic images do not provide adequate images of the ascending aorta. Magnetic resonance angiography or chest CT angiography are recommended in such cases for accurate diameter measurements.

However, this does not directly address the question of whether adults with coarctation of the aorta should undergo periodic imaging of the thoracic aorta.",70,"The RAG model's answer is mostly correct but lacks direct relevance to the question. It provides information on imaging techniques for thoracic aortic disease, but does not explicitly address the periodic imaging of the thoracic aorta in adults with coarctation of the aorta. The answer implies that imaging may be necessary in certain cases, but does not provide a clear recommendation.",73
Should exercise testing be performed in ACHD patients with unexplained symptoms or reduced exercise tolerance?,"Yes, exercise testing is recommended in ACHD patients with unexplained symptoms or reduced exercise capacity.","Based on the provided context, it is recommended that exercise testing be performed in patients with ACHD (Adult Congenital Heart Disease) and unexplained symptoms or reduced exercise tolerance. This is because exercise testing can help clarify symptom status, determine the etiology of symptoms, assess hemodynamic response to exercise, and provide prognostic information. In particular, exercise testing can help identify patients who are truly symptomatic, even if their clinical history is equivocal, and can guide the timing of intervention.",95,"The RAG model's answer is mostly correct and complete, providing a clear explanation of the benefits of exercise testing in ACHD patients with unexplained symptoms or reduced exercise tolerance. The only minor omission is the lack of specific mention of the type of exercise testing (e.g., treadmill, cardiopulmonary exercise testing) that is recommended.",74
Is pregnancy contraindicated in women with Eisenmenger syndrome?,"Yes, pregnancy is contraindicated in women with Eisenmenger syndrome due to high maternal and fetal risk.","Based on the provided context, there is no direct mention of Eisenmenger syndrome. However, Eisenmenger syndrome is a condition where pulmonary hypertension leads to systemic desaturation and right-to-left shunting. It is often associated with cyanotic congenital heart disease.

Eisenmenger syndrome can be associated with an increased risk of thromboembolic events, which is a consideration in pregnancy. However, the given context primarily focuses on anticoagulation in patients with mechanical heart valves, antiphospholipid antibodies, nephrotic syndrome, hypercoagulable states, and pulmonary hypertension associated with mitral stenosis and atrial fibrillation.

Given the information provided, it is uncertain whether pregnancy is contraindicated in women with Eisenmenger syndrome. However, pregnancy in patients with Eisenmenger syndrome is generally considered high-risk due to the associated cardiovascular complications. The risks associated with pregnancy in these patients might include increased mortality and morbidity for both mother and fetus.

In the absence of more specific information, a more general approach would be to suggest that women with Eisenmenger syndrome should undergo thorough evaluation and counseling about the risks and complications associated with pregnancy. A multidisciplinary team, including a cardiologist, obstetrician, and other specialists, should be involved in the decision-making process.",80,"The RAG model's answer is mostly correct but lacks directness and completeness. It acknowledges the risks associated with pregnancy in women with Eisenmenger syndrome but fails to provide a clear and definitive answer to the question. The answer also shifts focus to the evaluation and counseling process, which is secondary to the main question.",75
Should all patients have their haemoglobin concentration measured before major elective surgery?,"Yes, all patients should have haemoglobin checked prior to major elective surgery.","It is not explicitly stated that all patients should have their haemoglobin concentration measured before major elective surgery. However, it is mentioned that whether or not routine preoperative Hb determination is needed is controversial. 

In children younger than 1 year of age, routine preoperative Hb measurement is said to result in the detection of only a small number of patients with Hb concentrations of less than 10 g/dL, which rarely influences management of anesthesia or delays planned surgery. 

Therefore, it can be inferred that not all patients, especially those under 1 year of age, should have their haemoglobin concentration measured before major elective surgery, as it may not provide clinically significant information.",70,"The RAG model's answer is mostly correct with minor omissions. It correctly identifies the controversy surrounding routine preoperative Hb determination and provides a specific example of a patient group (children under 1 year of age) where routine measurement may not be necessary. However, it does not explicitly state that all patients should have their haemoglobin concentration measured before major elective surgery, which is the expected answer. The answer also lacks a clear conclusion or recommendation for the general population, making it incomplete.",76
Should alternatives to transfusion be discussed with patients before surgery where transfusion is anticipated?,"Yes, alternatives to transfusion should be discussed and documented before surgery.","Based on the provided context, the answer to the question is:

Yes, alternatives to transfusion should be discussed with patients before surgery where transfusion is anticipated.

This is stated in recommendation 2 of the guidelines, which says: ""Where blood transfusion is anticipated, this and alternatives to transfusion should be discussed with the patient before surgery, and their consent should be documented according to local protocols.""",100,"The RAG model's answer is fully correct and complete, accurately reflecting the medical recommendation and providing a clear explanation of its source.",77
How should peri-operative anticoagulants be managed?,They should be managed to balance the risk of bleeding with the risk of thrombosis.,"Based on the provided context, the management of peri-operative anticoagulants involves the following:

1. **Bridging Anticoagulation**: This refers to giving a short-acting anticoagulant, typically low-molecular weight heparin (LWMH), before and after surgery to minimize the time that patients are not anticoagulated, and thereby, to minimize the risk for thromboembolism.

2. **Indications**: Bridging anticoagulation is suggested in high-risk patients, not suggested in low-risk patients, and optional in intermediate-risk patients based on individual patient characteristics.

3. **Dosing Options**:
   - Subcutaneous (SC) therapeutic-dose LMWH: enoxaparin 1 mg/kg twice daily or 1.5 mg/kg once daily; dalteparin 100 IU/kg twice daily or 200 IU/kg once daily; or tinzaparin 175 IU/kg once daily.
   - Intravenous (IV) unfractionated heparin (UFH) to achieve a therapeutic activated partial thromboplastin time (aPTT) defined according to local laboratory parameters.
   - Low-dose LMWH for high-bleeding-risk surgery/procedure: enoxaparin 40 mg once daily; dalteparin 5000 IU once daily; or tinzaparin 4500 IU once daily.
   - For very-high-bleeding-risk surgery/procedure, post-operative therapeutic-dose LMWH bridging should be avoided; alternate options are low-dose LMWH or resuming warfarin alone.

4. **Monitoring**: There is no need for laboratory monitoring of bridging with SC LMWH. Monitoring is required for bridging with IV UFH (aPTT).

5. **Goals**: The management strategy aims to minimize periprocedural thrombosis, bleeding, mortality, inconvenience, and economic burden.",80,"The RAG model's answer is mostly correct and comprehensive, covering key aspects of peri-operative anticoagulant management, including bridging anticoagulation, indications, dosing options, monitoring, and goals. However, it lacks a clear statement on the balance between bleeding and thrombosis risks, which is the primary focus of the question. Nevertheless, the provided information is accurate and relevant to the topic, making it a mostly correct answer.",78
Is tranexamic acid recommended in patients at risk of blood loss greater than 500ml?,"Yes, tranexamic acid is recommended in patients where significant blood loss is possible.","Yes, tranexamic acid is recommended in patients at risk of blood loss greater than 500ml, as suggested in the dosing schedule for major trauma/non-cardiac surgery in Table 4. The recommended dose is 15 mg/kg-1 i.v. (max 1 g) over 10 min followed by 2 mg/kg-1 .h-1 infusion until closure or reduction of risk of haemorrhage.",90,"The RAG model's answer is mostly correct and complete, providing a specific dosing schedule for tranexamic acid in patients at risk of blood loss greater than 500ml. However, it does not provide a general recommendation or explanation for the use of tranexamic acid in this context, which is present in the expected answer.",79
Should blood sampling be managed carefully to minimise iatrogenic anaemia?,"Yes, iatrogenic anaemia should be minimised through appropriate blood sampling.","Yes, blood sampling should be managed carefully to minimize iatrogenic anaemia. This is explicitly stated in the recommendations under ""Minimising peri-operative blood loss"" as recommendation 5: ""Minimise iatrogenic anaemia by managing blood sampling appropriately.""",90,"The RAG model's answer is mostly correct, with a minor omission. It accurately states that blood sampling should be managed carefully to minimize iatrogenic anaemia, but it does not provide additional context or explanation, which would make it fully correct and complete.",80
Should obstetric bleeding be measured cumulatively?,"Yes, obstetric bleeding should be measured cumulatively with a clear escalation plan.","Yes, obstetric bleeding should be measured cumulatively. According to the provided text, every effort should be made to measure blood loss volumes cumulatively, with volumetric and gravimetric techniques after all deliveries, so escalation is based on actual rather than estimated blood loss.",90,"The RAG model's answer is mostly correct, but it could be more complete by explicitly stating the importance of a clear escalation plan in conjunction with cumulative measurement of obstetric bleeding.",81
Should every institution have a major haemorrhage protocol?,"Yes, every institution must have a regularly audited major haemorrhage protocol.","Yes, every institution should have a major haemorrhage protocol.",80,"The RAG model's answer is mostly correct, but it lacks the crucial detail of 'regularly audited' which is essential for a protocol to be effective and up-to-date. This omission reduces the completeness of the information, but the core idea of having a major haemorrhage protocol is still present.",82
Should group O red blood cells be available for immediate transfusion in life-threatening haemorrhage?,"Yes, group O RBCs should be readily available in life-threatening haemorrhage.","Yes, group O red blood cells should be available for immediate transfusion in life-threatening haemorrhage. According to the text, group O RBCs should be available immediately and transfused if haemorrhage is life-threatening, and group O RhD negative and K-negative RBCs should be prioritised in women of childbearing potential, children, and when the patient's sex is unknown.",90,"The RAG model's answer is mostly correct, but it includes an unnecessary reference to 'the text', which is not present in the expected answer. The RAG model's answer accurately conveys the medical accuracy and relevance to the question, but it could be improved by removing the extraneous phrase.",83
Should crystalloids be used routinely during major trauma haemorrhage?,"No, crystalloids should be avoided unless profound hypotension and no imminent blood available.","Based on the provided context, it appears that the use of crystalloids during major trauma hemorrhage is not recommended as routine practice. In fact, it states that ""Crystalloids should only be given where there is profound hypotension and no imminent availability of blood components."" This suggests that crystalloids should be used as a last resort, only when there is a critical need for volume resuscitation and blood components are not available.",90,"The RAG model's answer is mostly correct, with minor omissions. It accurately reflects the medical accuracy and relevance to the question, but does not explicitly state that crystalloids are not recommended due to their limited effectiveness in major trauma hemorrhage. However, the answer is still clear and conveys the correct message.",84
Should children receive blood components prescribed in units?,"No, children should receive blood components prescribed as volume (ml/kg).","Based on the provided context, the answer to whether children should receive blood components prescribed in units is no. According to the guidelines, blood components should be prescribed for children as a volume (ml/kg-1) rather than in units. This is to ensure that the correct volume of blood is transfused based on the child's weight, rather than the number of units.",100,"The RAG model's answer is fully correct and complete, accurately reflecting the medical guideline that children should receive blood components prescribed as volume (ml/kg) rather than in units, ensuring the correct volume of blood is transfused based on the child's weight.",85
What is the recommended transfusion threshold for FFP in major haemorrhage?,FFP is recommended if INR > 1.5.,"Unfortunately, there is no direct answer to the question based on the provided context as it does not explicitly mention the recommended transfusion threshold for FFP in major haemorrhage. However, the context does provide information on when to withhold FFP until four units of RBC have been given, unless the traumatic or atonic bleed is associated with other causes of early coagulopathy diagnosed on an early coagulation or VHA screen.

However, to provide a general answer, other guidelines for transfusion thresholds for FFP in major haemorrhage include:

- The World Health Organization (WHO) recommends a 1:1 ratio of FFP to RBCs for the first 2 units of RBC transfused, and then 1:2 to 1:3 ratio thereafter.
- The American College of Surgeons (ACS) recommends a 1:1 ratio of FFP to RBCs for the first 6 units of RBC transfused, and then 1:2 to 1:3 ratio thereafter.
- The European Society of Intensive Care Medicine (ESICM) recommends a 1:1 ratio of FFP to RBCs for the first 4 units of RBC transfused, and then 1:2 to 1:3 ratio thereafter.

Please note that these guidelines are subject to change and may not reflect the most up-to-date recommendations. The provided context does not specifically mention these guidelines, but they are generally accepted standards for transfusion thresholds in major haemorrhage.",70,"The RAG model's answer is mostly correct with minor omissions. It correctly identifies the general recommendation for FFP transfusion in major haemorrhage but fails to directly answer the question with a specific threshold. The provided information on guidelines from various organizations is relevant but not directly related to the question, making it partially correct but missing key information.",86
When should cryoprecipitate be given?,Cryoprecipitate should be given if fibrinogen < 1.5 g/L (< 2 g/L in obstetrics).,"Cryoprecipitate should be given 12 to 24 hours after the initial treatment, but in situations where control of bleeding is critical, it should be given sooner, specifically after major surgery.",30,"The RAG model's answer is partially correct but contains significant errors. It mentions giving cryoprecipitate 12 to 24 hours after initial treatment, which is incorrect. The correct answer focuses on the fibrinogen level as the primary indicator for giving cryoprecipitate, not the timing of treatment. The RAG model's answer also lacks this crucial information, making it incomplete and inaccurate.",87
What platelet threshold is recommended in obstetric haemorrhage?,Platelet transfusion should be given if platelet count is < 75 × 10⁹/L in obstetrics.,"Based on the provided context, the platelet threshold recommended in obstetric haemorrhage is < 75 × 10^9.l^-1 for transfusion, which is lower than the general recommendation of < 50 × 10^9.l^-1 given for patients who continue to bleed actively.",80,"The RAG model's answer is mostly correct, but it lacks clarity and precision in stating the general recommendation for patients who continue to bleed actively. The statement also uses a less conventional notation for the platelet count (10^9.l^-1) instead of the standard 10^9/L. However, the main point about the lower threshold in obstetric haemorrhage is correct.",88
Is restrictive transfusion strategy (Hb 70–80 g/L) safe?,"Yes, restrictive transfusion is safe and reduces unnecessary transfusions in stable patients.","Yes, a restrictive transfusion strategy (Hb 70–80 g/L) is considered safe. The strongest evidence supporting this comes from a systematic review and meta-analysis of RCTs, which found that patients who received RBC transfusions at a hemoglobin threshold of less than 70 g/L had similar outcomes to those who received transfusions at higher thresholds. Additionally, a specific trial (TRICC) demonstrated no difference in 30-day mortality between a restrictive transfusion strategy (Hb 70–80 g/L) and a liberal strategy (Hb 100 g/L) in euvolemic ICU patients.",90,"The RAG model's answer is mostly correct and complete, but it lacks a mention of the potential benefits of a restrictive transfusion strategy, such as reduced risk of transfusion-related complications and lower healthcare costs. The answer accurately cites the TRICC trial and a systematic review and meta-analysis of RCTs, providing strong evidence to support the safety of a restrictive transfusion strategy.",89
Should single-unit RBC transfusions be used in stable adults?,"Yes, single-unit transfusions are recommended in stable adults without active bleeding.","According to the provided context, single-unit RBC transfusions should be used in stable adults. The text states, ""Single-unit RBC transfusions are recommended in adult patients who are haemodynamically stable and without any evidence of active bleeding (or equivalent volumes calculated based on body weight for children or adults with low body weight (BMI < 18.5 kg.m -2 ))"" [33].",90,"The RAG model's answer is mostly correct, but it lacks a clear statement of recommendation. The provided text supports the use of single-unit RBC transfusions in stable adults, but the answer could be more direct and concise in stating that single-unit transfusions are recommended.",90
Is prophylactic FFP recommended before low-risk invasive procedures?,"No, prophylactic FFP is not recommended for correcting abnormal coagulation before low-risk procedures.","There is no mention of Fresh Frozen Plasma (FFP) in the provided context, so a recommendation on whether prophylactic FFP is recommended before low-risk invasive procedures cannot be made based on the provided information.",50,"The RAG model's answer is partially correct because it acknowledges the lack of information about FFP in the context, but it fails to address the actual question about the recommendation for low-risk invasive procedures. A more accurate response would be to provide the correct information about FFP recommendations for low-risk procedures, even if it's a 'no' recommendation.",91
Should prophylactic FFP be used in elective cardiac surgery?,"No, prophylactic FFP use is not recommended in elective cardiac surgery.","Based on the provided context, it does not provide a clear stance on whether prophylactic FFP (Fresh Frozen Plasma) should be used in elective cardiac surgery. The text focuses on preoperative evaluation and management of cardiac risk factors, with recommendations for stress testing, pharmacologic stress testing, and preoperative coronary angiography. There is no mention of FFP or its use in cardiac surgery.",70,"The RAG model's answer is mostly correct, but it lacks medical accuracy and completeness of information. The statement that the text does not provide a clear stance on FFP use is correct, but it does not address the actual question of whether prophylactic FFP should be used in elective cardiac surgery. A more accurate answer would be based on existing medical knowledge and guidelines, which would likely recommend against prophylactic FFP use in elective cardiac surgery.",92
Is cryoprecipitate the first-line therapy for fibrinogen replacement?,"Yes, cryoprecipitate is the standard concentrated source of fibrinogen.","Based on the provided context, fibrinogen concentrate is mentioned as a ""first-line therapy"" for replacing fibrinogen in many European countries, but it is not specified as the ""first-line therapy"" in all contexts. However, it is stated that ""clinical evidence for superiority of fibrinogen concentrates over cryoprecipitate is lacking."" 

In some contexts, cryoprecipitate is mentioned as a readily available and effective blood product for replacing fibrinogen, vWF, and other factors. However, it is also mentioned that fibrinogen concentrate is a suitable alternative.

Therefore, the answer to whether cryoprecipitate is the first-line therapy for fibrinogen replacement is not clear-cut, and the preference for either cryoprecipitate or fibrinogen concentrate may depend on the specific context and circumstances.",50,"The RAG model's answer is partially correct but missing key information. It acknowledges the context-dependent nature of fibrinogen replacement but fails to provide a clear stance on whether cryoprecipitate is the first-line therapy. The answer also introduces fibrinogen concentrate as a suitable alternative, which is relevant but not directly answering the question.",93
Is fibrinogen concentrate superior to cryoprecipitate?,"No, fibrinogen concentrate is not proven superior but may be non-inferior in cardiac surgery bleeding.","According to the context, the clinical evidence for the superiority of fibrinogen concentrate over cryoprecipitate is lacking. A recent large trial found that fibrinogen concentrate was noninferior to cryoprecipitate in patients who developed clinically significant bleeding and hypofibrinogenemia after cardiac bypass.",90,"The RAG model's answer is mostly correct, as it accurately states that fibrinogen concentrate is not proven superior to cryoprecipitate. However, it could be more complete by mentioning the specific context of cardiac surgery bleeding, which is crucial for understanding the comparison between the two treatments.",94
Are platelet transfusions recommended before central venous catheter insertion?,"Yes, if platelet count is below 20 × 10⁹/L.","No, platelet transfusions are not recommended before central venous catheter (CVC) insertion, according to the provided guidance. The recommended platelet count threshold for CVC insertion is 20 × 10^9.l^-1, and transfusions are not necessarily required to reach this threshold unless the patient has other risk factors.",80,"The RAG model's answer is mostly correct but lacks clarity on the necessity of transfusions to reach the recommended platelet count threshold. It correctly states that platelet transfusions are not necessarily required for CVC insertion, but this information is not directly relevant to the question of whether transfusions are recommended before CVC insertion. The answer also correctly states the recommended platelet count threshold.",95
What platelet count is required before lumbar puncture?,At least 40 × 10⁹/L before lumbar puncture.,"Based on the provided context, a platelet count of 40 × 10^9/L is required before lumbar puncture.",90,"The RAG model's answer is mostly correct, but it lacks a brief explanation or context, which is a minor omission. The medical accuracy and relevance to the question are correct, and the information is complete in terms of the required platelet count.",96
What platelet threshold is recommended for neurosurgery?,A platelet count of at least 100 × 10⁹/L is recommended for neurosurgery.,"For neurosurgery, the recommended platelet threshold is 100,000/mm^3. This is equivalent to 100 × 10^9/l.",90,"The RAG model's answer is mostly correct, but it uses the outdated unit 'mm^3' instead of the more commonly used '× 10^9/L' in modern medical literature. The information is relevant to the question and the medical accuracy is high.",97
Is PCC recommended for rapid reversal of warfarin in major bleeding?,"Yes, PCC is indicated for rapid reversal of warfarin in life-threatening bleeding.","Yes, PCC is recommended for rapid reversal of warfarin in major bleeding. According to the text, when there is life-threatening bleeding, recombinant activated factor VIIa (rFVIIa), three-factor PCC, or four-factor PCC can be given. Four-factor PCC is mentioned as appearing to be more effective than three-factor PCC in reversing warfarin.",90,"The RAG model's answer is mostly correct, with minor omissions. It accurately states that PCC is recommended for rapid reversal of warfarin in major bleeding and mentions the effectiveness of four-factor PCC over three-factor PCC. However, it does not explicitly state that PCC is indicated for life-threatening bleeding, which is a crucial aspect of the question.",98
Should vitamin K be co-administered with PCC?,"Yes, 5–10mg intravenous vitamin K should be given with PCC to maintain correction.","Yes, vitamin K should be co-administered with PCC (prothrombin complex concentrate) in certain situations, such as when there is life-threatening bleeding, or when administering PCC to reverse warfarin anticoagulation. According to the provided context, 5-10 mg of intravenous vitamin K should be given along with PCC due to the short half-life of factor VII (6 h).",90,"The RAG model's answer is mostly correct, with minor omissions. It accurately states that vitamin K should be co-administered with PCC in certain situations, but does not explicitly mention the situations where PCC is typically used (e.g. warfarin reversal, bleeding). The answer also correctly mentions the short half-life of factor VII and the recommended dose of intravenous vitamin K.",99
Is prehospital tranexamic acid beneficial within 3 hours of trauma?,"Yes, tranexamic acid within 3 hours reduces mortality in bleeding trauma patients.","Based on the provided context, the answer to the question is yes. According to the article ""Prehospital tranexamic acid for severe trauma"" by Gruen RL et al. (2023), published in the New England Journal of Medicine, prehospital tranexamic acid is beneficial within 3 hours of trauma.",90,"The RAG model's answer is mostly correct, but it lacks a direct statement about the reduction in mortality, which is a crucial aspect of the expected answer. The reference to the article is also not explicitly mentioned in the expected answer, but it is implied that the answer is based on evidence from a study.",100
Should crystalloids be given during uncontrolled haemorrhage?,"No, crystalloids should be avoided unless no blood products are available.","Based on the provided context, the answer to the question ""Should crystalloids be given during uncontrolled haemorrhage?"" is:

No, crystalloids should only be given where there is profound hypotension and no imminent availability of blood components.",80,"The RAG model's answer is mostly correct, but it lacks the crucial detail that crystalloids should be avoided unless no blood products are available, which is a more specific and accurate guideline in the context of uncontrolled haemorrhage.",101
What is the recommended restrictive transfusion threshold in ICU patients?,Hb < 70 g/L is recommended in most critically ill patients.,"The recommended restrictive transfusion threshold in ICU patients is a hemoglobin concentration of 70 g/L. However, it's essential to consider the patient's overall clinical status, and not rely solely on hemoglobin concentration for transfusion decisions.",90,"The RAG model's answer is mostly correct, but it could be more complete by providing more context or examples of when to consider the patient's overall clinical status. However, the core information about the recommended restrictive transfusion threshold is accurate and relevant to the question.",102
Is routine iron or erythropoietin therapy recommended in ICU anaemia?,"No, routine use of iron or erythropoietin is not recommended for ICU patients.","Based on the provided context, routine iron or erythropoietin therapy is not recommended in ICU anaemia. The current mainstay of treatment for anaemia in patients who are critically ill is RBC transfusion, with a restrictive transfusion threshold of Hb < 70 g/l recommended in most patients.",90,"The RAG model's answer is mostly correct, but it lacks a clear statement on the current guidelines and recommendations for erythropoietin therapy in ICU anaemia. The answer accurately reflects the mainstay of treatment for anaemia in critically ill patients, which is RBC transfusion with a restrictive transfusion threshold.",103
When should cell salvage be used in obstetric haemorrhage?,Cell salvage is recommended during caesarean section with abnormal bleeding.,"According to the provided context, cell salvage should be used in obstetric hemorrhage with caution. It is recommended in situations where blood loss exceeds 500 ml and when the patient is unable to receive donor blood. However, the use of cell salvage during cesarean delivery is not recommended without solid evidence and must be accompanied by the caution of severe hypotension.",70,"The RAG model's answer is mostly correct with minor omissions. It correctly identifies situations where cell salvage should be used in obstetric hemorrhage, such as when blood loss exceeds 500 ml and when the patient is unable to receive donor blood. However, it incorrectly states that cell salvage is not recommended during cesarean delivery without solid evidence, when in fact it is recommended in cases of abnormal bleeding.",104
what drugs are used to treat myocardial ischemia,"Antiplatelet drugs, nitrates, β-blockers, calcium channel blockers, and ACE inhibitors are used in the medical treatment of angina pectoris","The text discusses the medical treatment of myocardial ischemia, which includes the use of the following drugs:

1. Antiplatelet drugs:
   - Aspirin
   - Thienopyridines (clopidogrel and prasugrel)
   - Platelet glycoprotein IIb/IIIa inhibitors (eptifibatide, tirofiban, and abciximab)
   - Dipyridamole (not widely used)
   - Cangrelor and ticagrelor (new class of short-acting, reversible platelet inhibitors)

2. Nitrates
3. β-blockers
4. Calcium channel blockers
5. ACE inhibitors",90,"The RAG model's answer is mostly correct and complete, with a minor omission of specific examples under the nitrates category. The inclusion of newer antiplatelet drugs like cangrelor and ticagrelor is accurate, and the list of β-blockers, calcium channel blockers, and ACE inhibitors is comprehensive. However, the answer could be more detailed in the nitrates category, which is not a significant issue given the overall accuracy and completeness of the response.",105
when are nitrates contraindicated,"they are contraindicated in the presence of hypertrophic cardiomyopathy or severe aortic stenosis and should not be used within 24 hours of sildenafil, tadalafil, or vardenafil because of possible severe hypotension","Nitrates are contraindicated in the presence of:

1. Hypertrophic cardiomyopathy
2. (Ca2 )",70,"The RAG model's answer is mostly correct but missing key information. It correctly identifies hypertrophic cardiomyopathy as a contraindication for nitrates, but incorrectly leaves the second point blank. The correct information should be severe aortic stenosis, which is a common contraindication for nitrates. The answer also lacks information about the interaction with sildenafil, tadalafil, or vardenafil, which is a crucial point in the contraindication of nitrates.",106
what is the mortality rate of patients with STEMI who undergo aggressive reperfusion versus those that don't,with aggressive reperfusion the mortality is 6.5% and without from between 15 - 20%,There is no specific information in the provided context about the mortality rate of patients with STEMI who undergo aggressive reperfusion versus those that don't.,50,"The RAG model's answer is partially correct as it acknowledges the lack of specific information in the provided context, but it fails to provide any relevant information or context to support its claim, making it incomplete and not fully addressing the question.",107
when should beta (β) blockers be avoided in the setting of an MI,"they should not be given to patients in heart failure, who are in a low cardiac output state, or at risk of cardiomyopathy","The information provided does not directly address when beta (β) blockers should be avoided in the setting of an MI. However, according to the text, beta blockers are contraindicated in the presence of severe bradycardia, and abrupt withdrawal of beta blockers after prolonged administration can worsen ischemia in patients with chronic stable angina.",30,"The RAG model's answer is partially correct but significantly incomplete and inaccurate. It mentions contraindications not directly related to MI, such as severe bradycardia and abrupt withdrawal of beta blockers in chronic stable angina, and fails to address the key contraindications in the setting of an MI, which are heart failure, low cardiac output state, and risk of cardiomyopathy.",108
what are some common complication that occurs after MI,"acute pericarditis can occur 1 to 4 days after an MI in 10-15% of patients, also Mitral regurgitation, ventricular septal rupture, cardiac dysrhythmias, CHF, cardiogenic shock , acute myocardial rupture, ischemic or hemmorhagic stroke","Based on the provided context, some common complications that occur after a myocardial infarction (MI) include:

1. Cardiac dysrhythmias, especially ventricular dysrhythmias, which are a common cause of death during the early period following an acute MI.
2. Ventricular tachycardia, which can be treated with electrical cardioversion or intravenous lidocaine or amiodarone.
3. Ventricular fibrillation, which occurs in 3% to 5% of patients with acute MI and can be fatal if it occurs in patients with co-existing hypotension and/or congestive heart failure.
4. Intracardiac thrombus formation, especially in patients with infarction of the anterior wall and/or apex of the left ventricle, which can be detected by echocardiography and requires immediate anticoagulation with heparin followed by 6 months of anticoagulation with warfarin.
5. Perioperative myocardial ischemia, MI, and cardiac death in patients who have had a recent MI (8 to 30 days previously), acute MI (1 to 7 days previously), or unstable angina.
6. Complications related to coronary artery stent placement, such as acute coronary thrombosis and long-term patency of the vessel, which requires dual antiplatelet therapy and delayed elective noncardiac surgery for at least 6 weeks after a PCI with a bare metal stent and at least 12 months after a PCI with a drug-eluting stent.",70,"The RAG model's answer is mostly correct with minor omissions. It includes several common complications after MI, such as cardiac dysrhythmias, ventricular fibrillation, and intracardiac thrombus formation. However, it misses some key complications mentioned in the expected answer, such as acute pericarditis, mitral regurgitation, ventricular septal rupture, and cardiogenic shock. Additionally, the RAG model's answer includes some information that is not directly related to the question, such as perioperative myocardial ischemia and complications related to coronary artery stent placement.",109
how long do you need to wait for elective surgery after bare metal stent placement,"at least 6 weeks, 12 weeks preferable","For elective surgery after bare metal stent placement, it is recommended to wait at least 6 weeks (preferably 90 days) before undergoing surgery.",80,"The RAG model's answer is mostly correct, but it includes a minor error in the preferred waiting time. The expected answer states 12 weeks preferable, while the RAG model states 90 days, which is approximately 3 months. This discrepancy suggests a minor inaccuracy, but the overall recommendation of at least 6 weeks is correct.",110
how long should dual antiplatelet therapy be continued after a drug-eluting stent,1 year with drug eluting stents,"Based on the provided context, dual antiplatelet therapy (DAPT) should be continued for at least 1 year in patients with drug-eluting stents. However, if DAPT needs to be stopped, at least aspirin therapy should be continued. 

The recommendations for the continuation of DAPT vary depending on the type of stent:

- For bare metal stents, DAPT should be continued for at least 6 weeks.
- For drug-eluting stents, DAPT should be continued for at least 1 year.

It is essential to note that the longer one waits after stent placement, the better it is, as the risk of stent thrombosis decreases over time.",90,"The RAG model's answer is mostly correct and complete, providing accurate information on the duration of dual antiplatelet therapy for drug-eluting stents. However, it lacks specific details on the type of drug-eluting stents and the potential variations in DAPT duration based on individual patient factors, which might slightly reduce its completeness.",111
how long do you need to wait after stopping clopidogrel before performing a neuraxial technique?,7 days,"Based on the provided context, for a patient taking clopidogrel, it is recommended to wait at least 7 days after stopping the medication before performing a neuraxial technique to mitigate any potential bleeding risk.",100,"The RAG model's answer is fully correct and complete, accurately reflecting the medical recommendation to wait at least 7 days after stopping clopidogrel before performing a neuraxial technique to mitigate bleeding risk.",112
how long do you need to wait to have elective surgery after an MI,You need to wait 30 days,"Based on the provided context, the recommended waiting time after a myocardial infarction (MI) for elective noncardiac surgery is not directly mentioned. However, the context does mention the recommended waiting time after PCI (percutaneous coronary intervention) for elective noncardiac surgery.

For patients treated with a Bare Metal Stent (BMS), the recommended waiting time is at least 1 month after PCI.

For patients treated with a Drug-Eluting Stent (DES), the recommended waiting time is at least 3 months after PCI.",70,"The RAG model's answer is mostly correct with minor omissions. It correctly identifies the waiting times after PCI for elective noncardiac surgery, but it does not directly address the question of waiting time after an MI. The answer assumes that the context of PCI is relevant to the question, which may not be the case. A more complete answer would directly address the waiting time after an MI, which is typically 30 days.",113
what are the cardiac risk factors in patients undergoing elective major noncardiac surgery,"High risk surgery, ischemic heart disease, congestive heart failure (CHF), cerebrovascular disease, Insulin dependant diabetes, preoperative serum Cr of >2mg/dL","The cardiac risk factors in patients undergoing elective major noncardiac surgery are:

1. High-risk surgery
2. History of ischemic heart disease
3. History of congestive heart failure
4. History of cerebrovascular disease
5. Preoperative insulin-dependent diabetes mellitus
6. Preoperative serum creatinine level higher than 2.0 mg/dL",95,"The RAG model's answer is mostly correct and complete, with only a minor difference in the serum creatinine level threshold (2.0 mg/dL in the RAG model vs 2 mg/dL in the expected answer). The RAG model's answer accurately lists the cardiac risk factors in patients undergoing elective major noncardiac surgery, demonstrating a thorough understanding of the topic.",114
what is the risk of stroke in patients with both mitral stenosis and atrial fibrillation?,7 - 15% per year,"Based on the provided context, the risk of stroke in patients with both mitral stenosis and atrial fibrillation is about 7% to 15% per year.",90,"The RAG model's answer is fully correct and complete, accurately reflecting the medical consensus on the risk of stroke in patients with both mitral stenosis and atrial fibrillation. The only minor omission is the lack of specific references or sources to support the estimate, but the answer itself is medically accurate and relevant to the question.",115
what are intraoperative events that have a significant impact on mitral stenosis,"sinus tachycardia or afib with a rapid ventricular repsonse, overtransfusion or head-down positioning, drug-induced decreased SVR, hypoxemia or hypercarbia that may exacerbate pulmonary hypertension or cause right ventricular heart failure","Based on the provided context, intraoperative events that have a significant impact on mitral stenosis are not explicitly mentioned. However, the context mentions various studies and guidelines related to mitral stenosis, including its diagnosis, treatment options, and outcomes. 

Some studies discuss the importance of factors such as left ventricular systolic and diastolic function, transmitral gradient, and pulmonary artery pressure in patients with mitral stenosis. Others discuss the impact of comorbidities, such as atrial fibrillation and pulmonary hypertension, on the outcomes of patients undergoing surgery for mitral stenosis.

The context also mentions a study by Dahl JC, Winchell P, and Borden CW (1967) that reports long-term postoperative follow-up of patients with mitral stenosis. However, it does not specifically mention the intraoperative events that had a significant impact on the patients.

If we consider the broader context of cardiac surgery, intraoperative events that can have a significant impact on mitral stenosis include:

1. Intraoperative myocardial infarction
2. Cardiac arrest or ventricular fibrillation
3. Inadequate anesthesia or pain control
4. Hemorrhage or blood transfusion requirements
5. Intraoperative complications, such as left atrial appendage damage or cardiac tamponade.

However, these are general cardiac surgery complications and not specifically mentioned in the context as having a significant impact on mitral stenosis.",30,"The RAG model's answer is mostly incorrect because it fails to directly address the question and instead provides a general overview of mitral stenosis. The answer also includes unrelated information and general cardiac surgery complications, which are not relevant to the specific question about intraoperative events impacting mitral stenosis.",116
what are anesthetic considerations for patients with mitral regurgitation,"prevent bradycardia, prevent increases in systemic vascular resistance, minimize drug induced myocardial depression, and ","Based on the provided context, the anesthetic considerations for patients with mitral regurgitation include:

1. Maintenance of a normal to slightly increased heart rate to prevent severe left ventricular volume overload.
2. Avoidance of increases in systemic vascular resistance, which can cause decompensation of the left ventricle.
3. Use of vasodilator drugs such as nitroprusside to reduce afterload and improve left ventricular function.
4. Modest decreases in systemic vascular resistance to improve cardiac output.
5. Selection of anesthetic agents that do not increase systemic vascular resistance or decrease heart rate.
6. Use of regional anesthesia, which may be beneficial in some patients by decreasing systemic vascular resistance.
7. Monitoring for and prevention of events that can decrease cardiac output, such as excessive fluid administration, placement in Trendelenburg's position, or autotransfusion.
8. Avoidance of sudden decreases in systemic vascular resistance, which may not be tolerated and can decrease cardiac output.",80,"The RAG model's answer is mostly correct with minor omissions. It covers key points such as preventing bradycardia, avoiding increases in systemic vascular resistance, and minimizing drug-induced myocardial depression. However, it lacks a clear mention of preventing increases in left ventricular volume overload, which is a crucial consideration in patients with mitral regurgitation. Additionally, the answer could be more concise and directly address the question's requirements.",117
what are anesthetic considerations for patients with aortic stenosis,"maintain normal sinus rhythm, avoid bradycardia or tachycardia, avoid hypotension, optimize intravascular volume","The anesthetic considerations for patients with aortic stenosis include:

1. Prevention of hypotension, as it reduces coronary blood flow and can lead to myocardial ischemia and further deterioration in left ventricular function and cardiac output.
2. Maintenance of normal sinus rhythm, as the left ventricle is dependent on a properly timed atrial contraction to produce an optimal left ventricular end-diastolic volume.
3. Avoidance of sustained increases in heart rate, as it decreases the time for left ventricular filling and ejection and reduces cardiac output.
4. Aggressive treatment of hypotension to prevent cardiogenic shock and/or cardiac arrest.
5. Consideration of the time available for ventricular filling, ejection, and coronary perfusion when determining the heart rate.
6. Monitoring of cardiac output and taking measures to prevent a decrease in cardiac output.

These considerations are crucial to prevent perioperative cardiac complications and ensure a safe anesthetic management for patients with aortic stenosis undergoing noncardiac surgery.",80,"The RAG model's answer is mostly correct with minor omissions. It accurately addresses the importance of maintaining normal sinus rhythm, avoiding hypotension, and optimizing intravascular volume. However, it lacks a clear mention of avoiding bradycardia or tachycardia, which is a crucial point in the expected answer. The RAG model's answer also includes some additional points that are not explicitly mentioned in the expected answer, but are still relevant to the topic.",118
what are anesthetic considerations for patients with aortic regurgitation,"avoid bradycardia, avoid increases in systemic vascular resistance, minimize myocardial depression","The anesthetic considerations for patients with aortic regurgitation are:

1. Maintain a heart rate above 80 beats per minute to prevent bradycardia-induced volume overload.
2. Avoid abrupt increases in systemic vascular resistance, as it can precipitate left ventricular failure.
3. Use general anesthesia as the usual choice for patients with aortic regurgitation.
4. Use induction drugs that do not decrease heart rate or increase systemic vascular resistance.
5. Maintain modest increases in heart rate and modest decreases in systemic vascular resistance as reasonable hemodynamic goals during anesthesia.
6. Be prepared to treat left ventricular failure with vasodilators to reduce afterload and inotropes to increase contractility.
7. Monitor cardiac and renal function closely during surgery.",80,"The RAG model's answer is mostly correct with minor omissions. It correctly identifies the need to avoid bradycardia and increases in systemic vascular resistance, and provides some relevant information on managing left ventricular failure. However, it lacks specific details on induction drugs and does not fully address myocardial depression, which is a key consideration for patients with aortic regurgitation.",119
is mitral valve prolapse usual a concern?,"no, it's the most common form of valvular heart disease affecting 1-2.5% of the US population. It's usually benign.","Based on the provided context, mitral valve prolapse is a common cause of chronic primary mitral regurgitation (MR) in developed countries. The context states that mitral valve prolapse has a wide spectrum of etiology and presentation, and it can be divided into two main categories: myxomatous degeneration with gross redundancy of the valve components, which is more common in younger populations, and fibroelastic deficiency disease, which is more common in older populations.

In chronic primary MR, mitral valve prolapse is a significant concern because it can lead to volume overload, myocardial damage, heart failure, and eventual death if left untreated. Correction of the MR is curative, which makes mitral valve prolapse a critical factor to consider in the management of chronic primary MR.

However, the context also mentions that in chronic secondary MR, the mitral valve is usually normal, and the abnormal and dilated left ventricle causes papillary muscle displacement, which in turn results in leaflet tethering with associated annular dilation that prevents coaptation.",30,"The RAG model's answer is partially correct but contains significant errors. It overemphasizes the concern of mitral valve prolapse, stating it can lead to volume overload, myocardial damage, heart failure, and eventual death if left untreated. However, the original answer states that mitral valve prolapse is usually benign, affecting 1-2.5% of the US population. The RAG model's answer also fails to address the benign nature of mitral valve prolapse and its prevalence, making it a mostly incorrect response.",120
what are signs and symptoms of congenital heart disease in children?,"dyspnea, slow physical development, decreased exercise tolerance, heart murmur, clubbing, hypertension, squatting, congestive heart failure","The signs and symptoms of congenital heart disease in children include:

- Dyspnea
- Slow physical development
- Presence of a cardiac murmur
- Tachypnea
- Failure to gain weight
- Decreased exercise tolerance
- Heart rate >200 beats per minute
- Congestive heart failure
- Cyanosis
- Clubbing of digits
- Squatting
- Hypertension

Note that the presence of a cardiac murmur is a common sign of congenital heart disease in children.",80,"The RAG model's answer is mostly correct with minor omissions. It includes most of the expected signs and symptoms of congenital heart disease in children, but misses 'clubbing' and 'hypertension' in the expected answer's list, and incorrectly includes 'tachypnea' and 'heart rate >200 beats per minute', which are not specific to congenital heart disease in children.",121
what are cyanotic congential heart defects,"tetrology of fallot, transposition of the great vessels","Based on the provided context, Cyanotic Congenital Heart Defects are a group of heart defects that are characterized by cyanosis, which is a bluish discoloration of the skin due to inadequate oxygenation of the blood. The severity of cyanosis depends on the magnitude of the right-to-left shunt.

In the context of the text, the following specific Cyanotic Congenital Heart Defects are mentioned:

1. **Transposition of the Great Arteries with Intact Ventricular Septum**: This type of defect is characterized by cyanosis in the first week of life, with symptoms of respiratory distress and a nonspecific systolic ejection murmur.
2. **Transposition of the Great Arteries with VSD**: This type of defect is characterized by symptoms of congestive heart failure, such as tachypnea, tachycardia, sweating, and poor feeding, between 4 to 8 weeks of life, with relatively minimal cyanosis.
3. **Transposition of the Great Arteries with VSD and Pulmonary Stenosis**: This type of defect presents similarly to Group II, but with varying severity of symptoms based on the degree of pulmonary stenosis.

Additionally, **Ebstein's Anomaly** is also mentioned as a Cyanotic Congenital Heart Defect, characterized by a malformed tricuspid valve, right atrial dilation, and right ventricular hypoplasia, leading to cyanosis and symptoms of heart failure.

These defects are all associated with cyanosis, which is a key feature of Cyanotic Congenital Heart Defects.",70,"The RAG model's answer is mostly correct, but it lacks the specific mention of Tetralogy of Fallot, which is a well-known Cyanotic Congenital Heart Defect. Additionally, the answer could be more comprehensive by including other defects, such as Tricuspid Atresia and Hypoplastic Left Heart Syndrome, which are also characterized by cyanosis.",122
what is the most common congenital cardiac abnormality?,ventricular septal defect is the most common abnormality in 50% ,"The text does not explicitly state the most common congenital cardiac abnormality. However, it mentions that nine congenital heart lesions comprise more than 80% of congenital heart disease, but it does not specify which ones.",50,"The RAG model's answer is partially correct as it mentions that nine congenital heart lesions comprise more than 80% of congenital heart disease, but it fails to specify which ones, and does not directly address the question about the most common congenital cardiac abnormality.",123
"in full-term newborns, how quickly does the ductus arteriosus close",24 to 48 hours,"In full-term newborns, the ductus arteriosus closes functionally 10 to 15 hours after birth.",30,"The RAG model's answer is partially correct but significantly deviates from the expected answer, indicating a major error in medical accuracy. The expected answer specifies a closure time of 24 to 48 hours, while the RAG model's answer suggests a closure time of 10 to 15 hours, which is not supported by medical evidence.",124
what congenital heart defects result in a right to left intracardiac shunt?,"tetrology of fallot, eisenmenger's syndrome, ebstein's anomaly, tricuspid atresia, patent foramen ovale","The congenital heart defects that result in a right to left intracardiac shunt, according to the provided context, are:

1. Tetralogy of Fallot
2. Truncus arteriosus
3. Double-outlet right ventricle

These defects are characterized by increased resistance to flow in the right ventricular outflow tract, leading to right-to-left intracardiac shunting.",50,"The RAG model's answer partially correct but missing key information. Tetralogy of Fallot is correct, but truncus arteriosus and double-outlet right ventricle are not typically associated with right-to-left intracardiac shunts. Eisenmenger's syndrome, Epstein's anomaly, and tricuspid atresia are also relevant conditions that result in right-to-left shunting, which are not mentioned in the RAG model's answer.",125
what are the defects in tetralogy of fallot?,"large single VSD, aorta that overrides the right and left ventricles, obtruction to right ventricular outflow, right ventricular hypertrophy","The defects in Tetralogy of Fallot include:

1. Pulmonic stenosis (stenotic pulmonic valve or right ventricular outflow tract)
2. Ventricular septal defect (VSD)
3. Right ventricular hypertrophy
4. Overriding aorta (the aorta sits atop the VSD, receiving blood from both ventricles)

These four defects are often referred to as the ""tetralogy"" in Tetralogy of Fallot.",90,"The RAG model's answer is mostly correct, with minor omissions. The main difference is that the RAG model does not explicitly mention a large single VSD, which is a key characteristic of Tetralogy of Fallot. However, it does mention a VSD, which is correct. The rest of the information provided by the RAG model is accurate and relevant to the question.",126
what is the treatment of a hypercyanotic attack in tetralogy of fallot?,β-adrenergic antagonists such as esmolol or propranolol,"The treatment of a hypercyanotic attack in tetralogy of Fallot is influenced by the cause of the pulmonary outflow obstruction. The appropriate treatment is:

* If the cause is dynamic infundibular obstruction (spasm), administer β-adrenergic antagonists such as esmolol or propranolol.
* If the cause is decreased systemic vascular resistance, administer intravenous fluids and/or phenylephrine.
* The infant may be placed in the knee-chest position emergently.

Long-term oral propranolol therapy is indicated in patients who have recurrent hypercyanotic attacks caused by spasm of the outflow tract muscle.",90,"The RAG model's answer is mostly correct and complete, providing a detailed explanation of the treatment options for a hypercyanotic attack in tetralogy of Fallot. However, it slightly exceeds the expected answer by including additional information about the cause of the pulmonary outflow obstruction and the knee-chest position, which is not necessary to answer the question directly. Nevertheless, the core information about β-adrenergic antagonists and their administration is accurately presented.",127
what is the definition of eisenmenger's syndrome,when patients with a left to right intracardiac shunt have a reversal to right to left as a result of increased pulmonary vascular resistance to a level that equals or exceeds the systemic vascular resistance.,"There is no definition of Eisenmenger's syndrome in the provided context. The text appears to be discussing various medical conditions, including Wilms's tumor, Prader-Willi syndrome, and alcoholic myopathy, but Eisenmenger's syndrome is not mentioned.",100,"The RAG model's answer is incorrect because it fails to provide any information about Eisenmenger's syndrome, whereas the expected answer provides a clear and accurate definition of the condition.",128
what drugs caused drug induced heart rate increases?,"atropine or glycopyrrolate, sympathomimetic drugs, caffeine, nicotine, cocaine or amphetamines","Based on the provided context, the drugs that caused drug-induced heart rate increases are:

1. Ephedrine (Both   small effect)
2. Norepinephrine (Direct   Enhanced ß -stimulatory effect)
3. Phenylephrine (Indirect -  Diminished vasoconstrictive effects)",50,"The RAG model's answer partially correct but missing key information. It includes ephedrine, norepinephrine, and phenylephrine as correct examples of drugs that can cause heart rate increases, but it omits other crucial drugs such as atropine, glycopyrrolate, sympathomimetic drugs, caffeine, nicotine, cocaine, and amphetamines, which are also known to cause this effect.",129
what is the initial treament for SVT,vagal maneuvers like carotid sinus massage or valsalva maneuvers.  IV adenosine can be used,"The initial treatment for supraventricular tachycardia (SVT) in a hemodynamically stable patient is vagal maneuvers, such as carotid sinus massage or Valsalva's maneuver.",90,"The RAG model's answer is mostly correct and complete, but it lacks the mention of IV adenosine as an alternative treatment option for SVT. The answer accurately describes vagal maneuvers as the initial treatment for hemodynamically stable patients, making it a minor omission that does not significantly impact the overall correctness of the answer.",130
when is multifocal atrial tachycardia seen (MAT),it is commonly seen in patients with acute exacerbation of chronic lung disease,Multifocal atrial tachycardia (MAT) is most commonly seen in patients experiencing an acute exacerbation of chronic lung disease.,90,"The RAG model's answer is mostly correct and complete, with a minor omission of specifying the exact population (e.g., elderly patients) that is commonly affected by MAT. However, it accurately states that MAT is seen in patients with acute exacerbation of chronic lung disease, making it a highly accurate and relevant response.",131
what are the commong intravenous drug therapies for rate control with atrial flutter,"amiodarone, diltiazem, or verapamil","According to the provided context, the common intravenous drug therapies for rate control with atrial flutter are:

1. Amiodarone
2. Diltiazem
3. Verapamil

These drugs are helpful in controlling the ventricular rate, but none of these agents is likely to convert atrial flutter to sinus rhythm.",90,"The RAG model's answer is mostly correct, but it lacks a fourth option, which is adenosine, that is also used for rate control in atrial flutter. However, the three options provided (amiodarone, diltiazem, and verapamil) are accurate and relevant to the question, making it a mostly correct answer.",132
what are the potential causes of frequent PVCs,"acidosis, electrolyte abnormalities, use of prodysrhythmic drugs, and mechanical irritation from cardiac surgery or intracardiac or intrathoracic catheters","The potential causes of frequent PVCs include:

1. Underlying heart disease
2. Arterial hypoxemia
3. Myocardial ischemia or infarction
4. Valvular heart disease
5. Cardiomyopathy
6. QT interval prolongation
7. Digitalis toxicity
8. Electrolyte abnormalities (especially hypokalemia and hypomagnesemia)
9. Excessive caffeine use
10. Excessive alcohol use
11. Cocaine use

Additionally, an increased frequency of PVCs with exercise may be an indication of underlying heart disease.",80,"The RAG model's answer is mostly correct with minor omissions. It includes most of the potential causes of frequent PVCs, but misses acidosis and mechanical irritation from cardiac surgery or intracardiac or intrathoracic catheters. Additionally, it includes some less common causes like excessive caffeine use, excessive alcohol use, and cocaine use, which are not typically considered primary causes of PVCs.",133
what drugs are contraindicated in the treatment of wolff-parkinson-white syndrome?,"drugs that slow AV nodal conduction like adenosine, calcium channel blockers, beta-blockers, lidocaine and digoxin are contraindicated in WPW treatment","Based on the provided context, the following drugs are contraindicated in the treatment of Wolff-Parkinson-White (WPW) syndrome:

1. Haloperidol
2. Phenothiazines
3. Butyrophenones (e.g. droperidol)
4. Thioxanthines
5. Metoclopramide

These drugs can precipitate or exacerbate WPW syndrome.

Additionally, the following medications are contraindicated in patients with Parkinson's disease, which is related to WPW syndrome:

1. Beta-blockers (as they can decrease tremor)
2. Antidopaminergic medications (e.g. haloperidol, phenothiazines, butyrophenones)

However, it's worth noting that the main focus of the context is on the anesthesia care for patients with Parkinson's disease, WPW syndrome, and other conditions, and the contraindicated medications listed are mainly related to the treatment of Parkinson's disease and extrapyramidal symptoms, rather than WPW syndrome directly.",29,"The RAG model's answer is mostly incorrect because it lists medications contraindicated in patients with Parkinson's disease, which is unrelated to the treatment of Wolff-Parkinson-White syndrome. The correct answer focuses on medications that slow AV nodal conduction, which are contraindicated in WPW treatment.",134
what is the definition of hypertension?,when blood pressure measures 140/90 or higher,"According to the provided context, an adult is considered to have hypertension when the systemic blood pressure measures 140/90 mm Hg or higher on at least two occasions a minimum of 1 to 2 weeks apart.",90,"The RAG model's answer is mostly correct, but it lacks the context that the definition of hypertension can vary slightly depending on age, with different thresholds for adults and children. However, the provided answer is accurate for adults and meets the requirements of relevance and completeness.",135
what percent of hypertensive patients have obstructive sleep apnea?,0.3,"According to the context, approximately 30% of hypertensive patients have obstructive sleep apnea.",90,"The RAG model's answer is mostly correct, with a slight difference in wording. The expected answer is a specific percentage (0.3), while the RAG model's answer is an approximate percentage (30%). However, the RAG model's answer is still medically accurate and relevant to the question.",136
what are common causes of secondary hypertension?,"renovascular disease, hyperaldosteronism, aortic coarctation, pheochromocytoma, cushing's syndrome, pregnancy induced hypertension","According to the provided context, common causes of secondary hypertension are:

1. Renal artery stenosis leading to renovascular hypertension (most common cause of secondary hypertension)
2. Hyperaldosteronism (characterized by symptoms such as fatigue, weakness, headache, paresthesia, nocturnal polyuria and polydipsia, urinary potassium, serum potassium, plasma renin, and plasma aldosterone)
3. Aortic coarctation (characterized by elevated blood pressure in upper limbs relative to lower limbs and weak femoral pulses)
4. Pheochromocytoma (characterized by episodic headache, palpitations, and diaphoresis, paroxysmal hypertension, plasma metanephrines, urinary catecholamines, and spot urine metanephrines)
5. Cushing's syndrome (characterized by truncal obesity, proximal muscle weakness, purple striae, moon facies, hirsutism, dexamethasone suppression test, urinary cortisol, and adrenal CT scan)
6. Renal parenchymal disease (characterized by nocturia, edema, urinary glucose, protein, and casts, serum creatinine, renal ultrasonography, and renal biopsy)
7. Pregnancy-induced hypertension (characterized by peripheral and pulmonary edema, headache, seizures, right upper quadrant pain, urinary protein, uric acid, cardiac output, and platelet count)

Note that this is not an exhaustive list, as Table 5-3 provides a more comprehensive list of causes of secondary hypertension.",80,"The RAG model's answer is mostly correct with minor omissions. It includes most of the common causes of secondary hypertension, but misses renal parenchymal disease, which is a significant cause. The answer also includes pregnancy-induced hypertension, which is typically considered a primary cause rather than secondary. However, the RAG model's answer is still comprehensive and accurate in its description of each condition.",137
what is a hypertensive emergency?,"hypertensive emergency is when hypertensive patients have acute or ongoing end organ damage from hypertension, typically with a blood pressure more than 180/120","A hypertensive emergency is a situation where a patient's blood pressure is severely elevated (typically above 180/120 mm Hg) and they are experiencing evidence of acute or ongoing target organ damage, such as:

- Encephalopathy
- Intracerebral hemorrhage
- Acute left ventricular failure with pulmonary edema
- Unstable angina
- Dissecting aortic aneurysm
- Acute myocardial infarction
- Eclampsia
- Microangiopathic hemolytic anemia
- Renal insufficiency

In this situation, prompt pharmacologic intervention is required to lower the systemic blood pressure, with the goal of decreasing the diastolic blood pressure promptly but gradually to prevent coronary or cerebral ischemia.",95,"The RAG model's answer is mostly correct and complete, with a minor omission of the specific blood pressure threshold (typically above 180/120 mm Hg) in the initial statement. However, it provides a comprehensive list of target organ damage and accurate pharmacologic intervention guidelines, making it a highly accurate and relevant response to the question.",138
what are the clinical classifications of pulmonary hypertension?,"Pulmonary arterial hypertension, pulmonary hypertension owing to left heart failure, owing to lung diseases or hypoxia, chronic thromboembolic pulmonary hypertension, and pulmonary hypertension with unclear multifactorial mechanisms","The clinical classifications of pulmonary hypertension are as follows:

1. Pulmonary Arterial Hypertension (PAH)
   a. Idiopathic PAH
   b. Heritable PAH (BMPR2, ALK1, endoglin mutations)
   c. Drug and toxin-induced PAH
   d. PAH associated with Connective tissue diseases
   e. PAH associated with HIV infection
   f. PAH associated with Portal hypertension
   g. PAH associated with Congenital heart disease

2. Pulmonary Hypertension Owing to Left Heart Disease
   a. Left ventricular systolic dysfunction
   b. Left ventricular diastolic dysfunction
   c. Left ventricular noncompaction
   d. Cor pulmonale (right ventricular dysfunction due to left heart disease)

3. Pulmonary Hypertension Owing to Lung Diseases and/or Hypoxia
   a. Chronic Obstructive Pulmonary Disease (COPD)
   b. Interstitial Lung Disease (ILD)
   c. Other pulmonary diseases with mixed restrictive and obstructive pattern
   d. Sleep-disordered breathing
   e. Alveolar hypoventilation disorders
   f. Chronic exposure to high altitude

4. Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

5. Pulmonary Hypertension with Unclear Multifactorial Mechanisms
   a. Hematologic disorders: myeloproliferative disorders, splenectomy",80,"The RAG model's answer is mostly correct with minor omissions. It accurately lists the five main clinical classifications of pulmonary hypertension. However, it lacks further sub-classifications within each category, which are not explicitly mentioned in the expected answer but are commonly recognized in medical literature. The RAG model's answer is also more detailed and specific, which is a positive aspect, but it does not fully match the expected answer's brevity and simplicity.",139
what is the definition of pulmonary artery hypertension?,mean pulmonary artery pressure of more than 25 mm Hg at rest,Pulmonary artery hypertension (PAH) is defined in the context as a condition where there is high blood pressure in the arteries that supply blood to the lungs.,70,"The RAG model's answer is mostly correct in terms of medical accuracy, but it lacks completeness of information. It does not specify the pressure threshold, which is a crucial aspect of the definition. The answer is relevant to the question, but it could be more precise and detailed.",140
what are classic physical exam findings of LV failure?,"tachypnea and moist rales, resting tachycardia, s3 gallop.","Based on the provided context, classic physical exam findings of Left Ventricular (LV) failure are not explicitly mentioned. However, the provided text does mention classic physical exam findings of heart failure which include:

- Jugular venous distension (not explicitly mentioned, but implied under the context of symptoms leading to AVR)
- Rales or crackles on lung exam (not explicitly mentioned, but implied under the context of pulmonary edema)
- S3 heart sound (not explicitly mentioned, but implied under the context of heart failure)
- Edema (not explicitly mentioned, but implied under the context of symptoms leading to AVR)
- Decreased exercise capacity (as implied in the context of symptomatic pts with AR)

However, for specific information about LV failure, we would have to look at context that is more directly related to LV failure, such as context that is more directly related to LV failure from the information on echocardiography which includes:

- Decreased LV ejection fraction (LVEF)
- Increased left ventricular end diastolic diameter (LVEDD)

However, these echocardiographic findings are not physical exam findings, but rather diagnostic findings from an echocardiogram.",30,"The RAG model's answer is mostly incorrect because it fails to directly address the question about classic physical exam findings of LV failure, instead providing a list of symptoms and echocardiographic findings that are not directly relevant to the question. The answer also contains several inaccuracies and omissions, such as not mentioning tachypnea and resting tachycardia, which are key physical exam findings of LV failure.",141
